Medical | Business Upturn

KIMS Hospitals signs 60-year Amaravati land deal, plans major 500-bed healthcare expansion

Rashmi Pandey — Fri, 08 May 2026 14:45:31 +0000

KIMS Hospitals has signed a 60-year lease agreement with the Andhra Pradesh Capital Region Development Authority (APCRDA) for nearly two acres of land in Amaravati, marking a significant healthcare expansion in Andhra Pradesh.

According to the company, the leased land will be used to develop a new 500-bed multi-speciality hospital aimed at strengthening healthcare infrastructure in the state’s capital region.

The proposed facility is expected to offer advanced tertiary and quaternary care services across multiple medical specialties. The expansion also signals increasing private sector investment in Amaravati, which continues to position itself as a major administrative and infrastructure hub in Andhra Pradesh.

KIMS Hospitals said the agreement forms part of its broader growth strategy to expand its presence across southern India and improve access to high-quality healthcare services in emerging urban centres.

The company has not yet disclosed the total investment value or construction timeline for the proposed project. However, industry observers say the scale of the planned hospital indicates a major long-term commitment to the Amaravati region.

The development comes as Andhra Pradesh continues efforts to attract investments in healthcare, education and infrastructure sectors. Amaravati has remained a focal point for large-scale urban development projects following renewed policy attention toward the capital city’s expansion.

Healthcare demand in the region has also grown steadily in recent years due to population growth, urbanisation and rising requirements for advanced medical treatment facilities.

KIMS Hospitals operates a network of hospitals across several Indian cities and is known for providing services in cardiology, oncology, neurology, organ transplantation and critical care specialties.

The new hospital project is expected to create employment opportunities for healthcare professionals, administrative staff and support workers once operational. It may also improve access to specialised medical treatment for residents of Amaravati and surrounding districts.

The APCRDA has been involved in allocating land for infrastructure and institutional projects as part of the long-term development vision for Amaravati.

Further details regarding project approvals, construction phases and operational timelines are expected to be announced in the coming months.

Iran conflict triggers pharma shock: Are common medicines like paracetamol set to get costlier?

Rashmi Pandey — Fri, 17 Apr 2026 15:46:04 +0000

Common medicines, including Paracetamol, may soon become costlier in India, with chemists in Visakhapatnam warning of a potential 30–40% increase in drug prices amid global supply disruptions linked to the ongoing Iran-related geopolitical tensions.

According to inputs from local pharmaceutical traders and chemist associations, rising costs of raw materials and disruptions in international supply chains are beginning to impact the pricing of essential medicines. The situation has been attributed to escalating tensions involving Iran, which is affecting the availability and transportation of key pharmaceutical ingredients.

Industry sources indicate that Active Pharmaceutical Ingredients (APIs), many of which are sourced globally, are witnessing price fluctuations due to increased freight costs, insurance premiums, and logistical uncertainties. These factors are contributing to a broader “pharma cost shock,” which is expected to reflect in retail medicine prices in the coming weeks.

Chemists in Visakhapatnam have cautioned that widely used over-the-counter drugs like paracetamol could be among the first to see price hikes, given their high demand and dependence on stable supply chains. The warning highlights concerns among retailers and distributors regarding stock availability and procurement costs.

The pharmaceutical supply chain is closely tied to global trade routes, and any disruption—particularly in energy corridors and shipping lanes—can have a cascading effect on manufacturing and distribution. Increased transportation costs and delays are already being reported by industry participants.

As of now, there has been no official notification from regulatory authorities regarding price revisions. However, stakeholders within the pharmaceutical sector have indicated that if current conditions persist, a price adjustment may become unavoidable.

The situation continues to be monitored by industry players, with further clarity expected based on developments in global markets and supply chain stability.

SUMEET SSG brings European EMS equipment to Maharashtra’s 108 Ambulance Fleet

Riddhima Jain — Thu, 16 Apr 2026 04:44:56 +0000

Pune-based SUMEET SSG has partnered with Spencer India to equip 1,756 ambulances under Maharashtra’s MEMS 108 project with advanced emergency medical equipment.

The multi-year partnership will cover a phased deployment of globally certified stretchers, evacuation systems, immobilisation devices and rescue equipment across the statewide emergency fleet.

The initiative is part of the MEMS 108 program being executed by Sumeet SSG BVG Maharashtra EMS under a 10-year PPP-DBFOT model to strengthen pre-hospital care and emergency response systems.

“Our partnership with Spencer marks a defining moment for emergency medical services in India. MEMS 108 is not just a fleet; it is a complete life-saving ecosystem,” said Summit Salunke, Chairman, SUMEET SSG.

Mr. Manish Malik, MD, Spencer India added, “The partnership will be implemented over several years, starting with phased deployment in the near future. Full fleet integration is expected to occur in later phases. This initiative will position MEMS 108 as one of the first state-wide Emergency Medical Services (EMS) networks in India to adopt a fully European-standard pre-hospital care ecosystem on a large scale.”

The companies said the rollout will position MEMS 108 among the first state-wide EMS networks in India to adopt a European-standard pre-hospital care ecosystem at scale.

Bihar bans private practice for allopathic doctors in state health services

Rashmi Pandey — Sat, 11 Apr 2026 14:25:56 +0000

The Bihar government has agreed to the Health Department’s proposal to ban private practice for doctors, physician‑teachers, and other allopathic‑system medical staff belonging to the state’s main health‑service cadres. The decision covers the Bihar Health Services Cadre, Bihar Medical Education Services Cadre, and Indira Gandhi Institute of Medical Sciences (IGIMS) Medical Services Cadre working under the allopathic system of medicine, according to official circulars and state‑level communications on 11 April 2026. The measure is framed as part of an effort to ensure that publicly funded medical professionals devote their full working hours to government hospitals and teaching institutions rather than splitting time between state duties and private clinics.

Under the new arrangements, physicians and medical teachers in these three cadres will no longer be allowed to conduct paid private consultations, run profit‑oriented clinics, or operate in private hospitals on the same days they are on government duty in the state’s health system. The directive is being treated as an amendment to existing service rules for these cadres, and the Health Department has indicated that violations may be booked under disciplinary and, where applicable, legal provisions. The department has also said that the ban is aimed at bridging the perceived gap between public‑sector availability and the long‑standing practice of senior government doctors running parallel private practices.

The Health Department’s proposal highlights that the move is intended to improve in‑patient availability at government hospitals, reduce absenteeism, and strengthen medical teaching in state institutions by keeping more senior clinical staff in public‑sector roles. It notes that the breadth of the cadres, spanning district hospitals, medical colleges, and the premier IGIMS‑linked services, makes the regulation a wide‑ranging step rather than a narrow, department‑specific order. The department has said that the order will be formally notified through the state’s service rules‑amendment process, and that implementation will be monitored by the Health Secretary‑level machinery in coordination with hospital‑level grievance‑handling mechanisms.

The decision is likely to spark debate among doctors’ associations, which have previously contested similar bans as an infringement of professional rights, and among patient groups, who rely on the same clinicians in both public and private domains. The government has indicated that the policy is not a blanket prohibition on all professional activity but a targeted restriction on private, profit‑driven clinical work that overlaps with state‑service hours.

SUMEET SSG partners Pinnacle Industries for Maharashtra MEMS 108 ambulance fleet

Riddhima Jain — Thu, 09 Apr 2026 05:00:11 +0000

SUMEET SSG has partnered with Pinnacle Industries to design and deliver ambulance body kits for Maharashtra’s MEMS 108 project, aimed at strengthening the state’s emergency medical services.

Under the agreement, Pinnacle Industries will develop 255 Advanced Life Support (ALS), 1,274 Basic Life Support (BLS), and 36 neonatal ambulances. The fleet will be deployed across all 36 districts of Maharashtra.

The project will be implemented by Sumeet SSG BVG Maharashtra EMS, a joint venture between Sumeet Group, BVG India Ltd., and SSG Transporte Sanitario (Spain), under a 10-year PPP-DBFOT model. A total of 1,756 emergency vehicles will be deployed and operated.

“Pinnacle Industries brings unmatched expertise in ambulance fabrication, and their partnership is critical to the success of MEMS 108. Our fleet must be strong, reliable, safe, and clinically optimised. Pinnacle’s proven engineering capability ensures that every ambulance we deploy meets the standards required for world-class emergency response.” said Summit Salunke, Chairman, SUMEET SSG.

“We are proud to partner with SUMEET SSG on a project of this scale and importance. At Pinnacle Industries, our focus has always been on engineering excellence and patient-centric design. Through this initiative, we aim to enhance emergency response capabilities and contribute meaningfully to saving lives.” said Mr. Sachin Deshmukh, Executive Director, Pinnacle Industries Limited.

The initiative aims to improve pre-hospital care and emergency response through integrated systems and advanced medical mobility solutions.

Oral weight-loss breakthrough: Foundayo hits market with $25 insured pricing

Rashmi Pandey — Wed, 01 Apr 2026 16:00:19 +0000

Eli Lilly and Company has outlined pricing and distribution details for Foundayo (orforglipron), its newly approved oral GLP‑1 receptor agonist for weight loss, following U.S. Food and Drug Administration approval earlier this week. The company confirmed that the medicine will be available through its direct‑to‑patient platform LillyDirect, with multiple pricing options designed to broaden access for patients across insurance types.

Foundayo is approved for adults with obesity or overweight with weight‑related medical conditions and represents a significant development in the rapidly expanding market for oral weight‑loss therapies. Unlike injectable GLP‑1 medications, Foundayo can be taken once daily without restrictions on food or water timing, offering convenience for patients.

Access and pricing structure

According to company announcements, Foundayo will be made available through LillyDirect, where prescriptions are being accepted immediately and shipping will begin on April 6. Patients and healthcare providers can begin ordering Foundayo through this direct channel before broader pharmacy availability.

Under the pricing plan:

Patients with commercial insurance may pay as little as $25 per month using the Foundayo savings card administered through LillyDirect.
Self‑pay patients without insurance coverage will have access to the medication starting at $149 per month for the lowest dose through LillyDirect.
Qualified Medicare Part D beneficiaries may be eligible to obtain Foundayo at approximately $50 per month beginning July 1, 2026, under certain plan provisions negotiated between the company and Medicare coverage programs.

Clinical and market context

Foundayo’s FDA approval marks a milestone for oral obesity therapies. GLP‑1 receptor agonists have transformed weight‑loss treatment options in recent years, historically dominated by injectable drugs. Foundayo’s convenience and pricing strategy reflect Lilly’s effort to compete in a segment expected to grow substantially as insurers and government programs expand coverage.

The drug is recommended to be taken in conjunction with a reduced‑calorie diet and increased physical activity, and company literature warns that combining Foundayo with other GLP‑1 receptor agonists is not advised, given overlapping mechanisms and potential safety concerns.

Insurance and policy considerations

Access for Medicare Part D beneficiaries is a key development for the market, as cost concerns have historically limited uptake of weight‑loss medications among older adults. Company disclosures indicate that eligible Medicare plans may cover Foundayo under cost‑sharing arrangements, enabling beneficiaries to pay around $50 per month starting mid‑2026, though final plan participation and actual costs may vary across insurers and formularies.

Health policy experts have previously noted that not all Medicare plans may adhere to a strict $50 cap, and actual out‑of‑pocket costs could differ based on plan design and coverage determinations.

Commercial outlook

Foundayo enters a market where pricing strategies play a critical role in patient access and uptake. Direct pricing via LillyDirect aims to reduce barriers for both insured and uninsured patients, positioning Foundayo competitively alongside other GLP‑1 therapies that have launched with similar direct‑to‑consumer initiatives.

Industry analysts anticipate that accessible price points and broader insurance coverage will influence market dynamics and utilization patterns for oral weight‑loss medications, particularly as healthcare providers integrate these treatments into obesity management strategies.

Apollo Hospitals expands air ambulance network to speed up critical care access : 1066 EMS to act as central coordination hub for domestic and global transfers

Riddhima Jain — Tue, 31 Mar 2026 06:00:02 +0000

Apollo Hospitals has announced a structured patient transfer initiative to improve access to critical care through coordinated air ambulance services across India and international markets.

The hospital group has signed MoUs with multiple domestic and international air ambulance operators to streamline patient transfers. The initiative will be coordinated through Apollo’s 1066 Emergency Response Network, which will serve as the central hub for managing requests and logistics.

The partnerships aim to address gaps in emergency transport, particularly in remote and underserved regions, where patient transfers are often fragmented and costly. The model integrates ground ambulance support, airport connectivity and air transfers to enable bed-to-bed movement.

“In critical situations, the ability to reach the right hospital quickly can make a life-saving difference. Through our partnerships with specialised air ambulance providers, we are making it easier for patients and families to access advanced care across cities and across borders, in a more coordinated and transparent manner,” said Dr. Preetha Reddy, Executive Vice Chairperson, Apollo Hospitals.

The initiative is expected to support faster and more organised transfers for high-acuity cases requiring tertiary and quaternary care.

Smart Medical Coat Developed in Bhilai to Monitor Heart and Lung Health

News Desk — Thu, 19 Mar 2026 04:55:08 +0000

Research by Rungta International Skills University receives patent recognition by Government of India

In a major breakthrough in health technology, researchers at Rungta International Skills University in Bhilai have developed a smart medical coat that helps monitor heart and lung health in real-time. The research has received patent recognition by the Government of India, creating a major milestone in health technology emerging from Chhattisgarh.

The smart coat has been developed to monitor health parameters even when worn, helping identify major health issues related to heart, lung, and respiratory problems. The technology is expected to go beyond conventional methods of health check-ups, helping monitor health parameters continuously.

The technology was developed under the guidance of Pro Chancellor Dr. Sourabh Rungta, along with researcher Dr. Sandeep Bhad, who played an integral part in this research.

Continuous Monitoring Using Wearable Technology

The smart coat utilizes wearable technology by incorporating sensors that allow for continuous monitoring of a user’s health while wearing a coat that is comfortable for daily activities. Once the user puts on the coat, the smart coat continuously monitors key health indicators such as heart rate, breathing patterns, levels of oxygen in the blood, and body temperature.

The smart coat is then able to identify unusual patterns in the user’s health indicators and send early warning signals for any possible health risks that may occur.

According to the research team that developed the smart coat, the device has the ability to detect early signs of any possible health risks that may occur due to respiratory distress, irregular heart beats, and fluctuations in levels of oxygen in the blood. This device has the ability to help individuals who need constant monitoring of their health, especially the elderly.

Solar-Powered Sensors and Real-Time Data

The smart medical coat has biosensors that utilize solar fabric technology. The technology allows the biosensors to operate while the smart medical coat is being worn. The biosensors collect data and process it using a digital monitoring system.

The technology can monitor unusual changes in a person’s physical condition. The system can send alerts when necessary. The technology can also be useful for remote monitoring. The technology can help doctors and caregivers monitor patients effectively.

Clinical Trials in the Next Phase

The research team is currently preparing for clinical trials, which will be the next step toward evaluating the effectiveness of the smart medical coat in real-world healthcare settings. The proposal will be submitted to relevant regulatory authorities for approval before wider deployment.

Experts believe that wearable technologies like the smart coat could play a significant role in preventive healthcare, helping detect medical conditions early and reducing the need for emergency interventions.

The development reflects the growing emphasis on innovation-driven research in Indian universities and highlights the potential of academic institutions in contributing to the future of digital healthcare.

Rising Air Pollution May Contribute to Male Infertility: Study!

Riddhima Jain — Tue, 17 Mar 2026 05:15:43 +0000

A nationwide research study by Indira IVF suggests worsening air pollution could be contributing to declining sperm DNA health among men in urban areas.

The study found that men living in regions with AQI levels above 151 recorded an 11% drop in normal sperm integrity compared to those in cleaner environments.

Researchers analysed 3,222 men aged between 21 and 40 across 120 Indira IVF centres nationwide, focusing specifically on sperm DNA integrity rather than traditional semen parameters.

According to the study, 69.3% of sperm samples were normal in areas with AQI levels between 50 and 100, but the proportion declined as pollution levels increased.

In moderately polluted regions with AQI levels between 101 and 150, normal sperm levels fell by 8.8%, while in highly polluted areas (AQI above 151) the decline reached 11%.

Commenting on the research, Dr. Kshitiz Murdia, CEO & Whole-Time Director, Indira IVF Hospital Limited, said, “The implications of these findings go beyond conception challenges. Prolonged exposure to pollution can affect sperm DNA integrity, which may also affect foetal development. In this study, patients were categorised based on sperm DNA fragmentation scores, with normal defined as less than 25% fragmentation and abnormal as greater than 25%, allowing us to closely assess how different air quality levels impact sperm chromosome integrity. Our observations suggest that rising air pollution levels can serve as a reliable indicator for disturbed sperm DNA fragmentation, significantly impacting Sperm DNA integrity, more-so in high-pollution urban centres.”

Dr. Vipin Chandra, Chief of Clinical and Lab Operations, Indira IVF Hospital Limited said, “We analysed a statistically significant cohort of 3,222 men aged 21 to 40 across 120 Indira IVF centres nationwide. Rather than focusing on conventional semen parameters such as sperm count or motility, the study specifically examined sperm DNA integrity. This enabled a more precise assessment of how exposure to air pollution directly impacts the genetic structure of sperm, offering deeper insight into an often-overlooked contributor to male infertility.”

These findings align with the growing burden of male infertility observed in recent years in highly polluted urban areas.

Ovulation Calculator: How to Find Your Most Fertile Days for Pregnancy

News Desk — Sat, 14 Feb 2026 18:25:42 +0000

Planning a pregnancy can feel both exciting and overwhelming for a couple, especially first-time parents. Certain questions can also arise quickly, like When is the right time? Am I fertile today? Why does timing matter so much? While conception depends on multiple biological factors, one element plays a decisive role: ovulation.

Understanding when ovulation occurs can dramatically improve the chances of pregnancy, and this is where an Ovulation Calculator becomes a valuable companion.

Rather than guessing or relying solely on physical signs, modern tools provide clarity by translating menstrual data into fertile windows. When used correctly, they simplify one of the most complex aspects of conception planning.

What Ovulation Really Means in the Fertility Journey?

Ovulation is the process by which an ovary releases a mature egg. Once released, that egg survives for about 12 to 24 hours. This overlap creates a short fertile window each cycle when pregnancy is most likely to occur.

Because this window is limited, timing becomes crucial. Missing it by even a couple of days can significantly reduce the chances of conception in that cycle.

Let’s Understand: Ovulation Calculator and Its Work?

An Ovulation Calculator estimates fertile days based on cycle length and the first day of the last menstrual period. Most ovulation events occur roughly 12–14 days before the next period begins, regardless of overall cycle length.

After a pattern is studied and analysed, the calculator predicts the days when ovulation is most likely to happen. It then highlights the fertile window, which typically is five days before ovulation and the day of ovulation itself. This provides couples a clear timeframe for planning intimacy.

Know Your Fertile Window

Trying to conceive without understanding ovulation can often lead to frustration. Many couples assume pregnancy can happen anytime during the month, which is not accurate in biological terms.

Focusing efforts during the fertile window increases success rates without adding stress or unnecessary medical intervention. It also helps couples avoid burnout by replacing constant attempts with strategic timing.

Signs That Support Ovulation Predictions

While calculators provide estimates, combining them with physical observations improves accuracy. Changes in cervical mucus are one such indicator. Around ovulation, mucus often becomes clear, stretchy, and slippery. This is similar to egg whites which create an ideal environment for sperm.

Some women experience mild pelvic discomfort known as mittelschmerz. Others notice increased libido or heightened senses. Tracking these patterns alongside calculated dates offers a fuller picture of fertility rhythms.

Let’s Understand: Irregular Cycles and Ovulation Tracking

Not everyone has predictable cycles. Stress, weight changes, hormonal conditions, or lifestyle disruptions can shift ovulation timing. In such cases, calculators still offer guidance, but additional tracking methods such as basal body temperature or ovulation predictor kits may help refine estimates.

Irregular patterns do not automatically mean infertility. But they do require closer observation and patience for a better understanding of the issue.

How Long Should You Try Before Seeking Help?

For most healthy couples under 35, trying for up to a year is considered normal before consulting a specialist. For those over 35, medical advice is often recommended after six months.

Using an ovulation tool during this period ensures attempts are well-timed. If conception doesn’t occur despite accurate tracking, a healthcare provider can explore underlying causes and suggest next steps.

Why is Emotional Balance Important While Tracking Fertility?

Fertility tracking can sometimes feel mechanical, reducing intimacy to dates on a calendar. This might also feel like a technical process to some couples. Thus, it’s important to maintain emotional connection and avoid letting numbers dominate the relationship.

Using an Ovulation Calculator should support and not control the journey. Flexibility, communication, and emotional care are just as important as biological timing.

Let’s Understand: Pregnancy Planning and Financial Preparedness

Once a couple firmly decides to have a baby, thinking ahead about healthcare coverage makes sense. Antenatal visits, diagnostic tests, delivery costs, and postnatal care all involve expenses.

Exploring maternity insurance policies early allows couples to understand waiting periods, coverage limits, and hospital networks. Many plans require enrollment well before conception, making early research essential.

Combining fertility awareness with financial planning creates a more secure foundation for parenthood.

When are Ovulation Calculators Most Effective?

These tools are most effective for women with relatively consistent menstrual cycles. Over time, entering accurate data improves prediction reliability. Even with minor variations, calculators offer a structured starting point.

They are not diagnostic tools but planning aids. Medical evaluation remains important if conception challenges persist.

How Do Lifestyle Choices Support Fertility?

Ovulation responds positively to balanced nutrition, adequate sleep, moderate exercise, and stress management. Extreme dieting or overtraining may disrupt hormonal balance.

One should avoid smoking, limit alcohol, and manage chronic conditions to support reproductive health.

Conclusion

Pregnancy planning is a combination of science, patience, and emotional readiness for couples. An Ovulation Calculator removes guesswork, replacing uncertainty with clarity. By identifying fertile days, it empowers couples to align timing with biology rather than chance.

When a couple blends both physical and financial strengths, including reviewing maternity insurance policies, the path toward parenthood feels more confident and less overwhelming.

Sun Pharma gets DCGI nod to manufacture and market generic semaglutide injection in India

Aman Shukla — Fri, 23 Jan 2026 02:57:08 +0000

Sun Pharmaceutical Industries Limited has received approval from the Drugs Controller General of India (DCGI) to manufacture and market a generic version of semaglutide injection in the country. Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that is indicated for chronic weight management in adults, to be used as an adjunct to a reduced-calorie diet and increased physical activity. This development marks a significant step in expanding access to GLP-1–based therapies in the Indian pharmaceutical market.

The company plans to launch the generic semaglutide injection under the brand name Noveltreat after the expiry of the semaglutide patent in India. The approval has been granted following a detailed review of a Phase III clinical trial conducted within the country, underscoring regulatory clearance based on India-specific clinical data. Noveltreat will be available in five dose strengths—0.25 mg/0.5 mL, 0.5 mg/0.5 mL, 1 mg/0.5 mL, 1.7 mg/0.75 mL, and 2.4 mg/0.75 mL—with a recommended maintenance dose of 2.4 mg administered once weekly.

Noveltreat will be offered through an easy-to-use prefilled pen, designed to support accurate dosing and improve patient convenience. The once-weekly administration format aligns with existing global treatment practices for semaglutide, potentially supporting better adherence among patients undergoing long-term weight management therapy.

Separately, in December 2025, Sun Pharma had already received DCGI approval to manufacture and market semaglutide injection for the treatment of adults with insufficiently controlled type 2 diabetes mellitus, as an adjunct to diet and exercise. This formulation is planned to be launched under the brand name Sematrinity, also after the expiry of the semaglutide patent in India.

Why Niva Bupa Health Insurance Is a Trusted Choice for Indian Families

News Desk — Wed, 21 Jan 2026 12:48:50 +0000

Let’s be honest, choosing a health insurance provider in India can feel overwhelming. Between complex policy wordings, endless add-ons, and the fear that a company might disappear when you need it most, it’s easy to feel lost. You’re not just buying coverage. You’re buying peace of mind for your parents, your spouse, your children. You’re placing a bet on a promise that must be kept, perhaps years from now.

Over a decade of writing about finance and family well-being, I’ve learned that trust in this sector isn’t built overnight. It’s earned through consistency, transparency, and a genuine understanding of what Indian families go through when illness strikes. One name that has consistently stood out in these conversations in living rooms from Chennai to Chicago is Niva Bupa.

A Legacy of Focus: Health-Only Expertise

Many insurers in India offer health plans as just one product among many, cars, homes, travel. Niva Bupa is different. It’s a standalone health insurance company, a joint venture between India’s Niva Group and the international Bupa group. This focus matters. It means their entire system from claim assessors to customer service is built specifically for healthcare. There’s no confusion, no passing the file to another department. Health is their only business.

Clarity Over Complexity: The “No Hidden Clause” Promise

If there’s one thing that erodes trust, it’s fine print. How many times have you heard, “Sorry, that’s not covered”? Niva Bupa has built a strong part of its reputation on combating this very fear. Their “Health First” philosophy is backed by policies like their flagship ReAssure plan, which famously offers no pre-medical screening up to a specified age and sum insured. This is a game-changer for families including ageing parents or those managing pre-existing conditions.

But beyond that, they strive for policy wordings that are clearer, with fewer surprise exclusions. In an industry often criticised for opacity, this commitment to clarity isn’t just marketing, it’s a foundational pillar that gives families the confidence to actually use their insurance, not just hold a policy they’re afraid to claim on.

Designed for Real Indian Family Life

Indian families have unique dynamics. We often have multiple generations under one financial umbrella. A good health insurance must reflect that. Niva Bupa’s product suite does this thoughtfully.

Their family floater plans often include benefits like automatic restoration of the sum insured after exhaustion crucial in case of a prolonged illness. They cover a wide range of day-care procedures (over 500), recognising that many modern treatments don’t require 24-hour admission. Their network of cashless hospitals is vast and includes many top-tier and mid-tier facilities across the country, ensuring access in metros and smaller cities alike.

The Intangible: A Reputation for Being There

Metrics like Claim Settlement Ratio (CSR) are vital, and Niva Bupa consistently maintains a strong one. But trust is also built in the stories that don’t make the annual report. It’s in the proactive call from a customer service agent during a stressful hospital admission. It’s in the efficient handling of a cashless request without unnecessary friction. It’s in the renewal process that doesn’t feel like a battle.

Over the years, this is the feedback I’ve heard repeatedly from clients and readers: “They were straightforward.” “They paid without hassle.” In the vulnerable moments that define a health crisis, this humane and efficient response is what transforms a company from a service provider into a trusted ally.

The Final Verdict: A Choice of Confidence

Choosing Health Insurance is a profound responsibility. Niva Bupa has cultivated trust not by being the cheapest or the loudest, but by being reliably present. They’ve combined focused expertise, a push for transparency, and products built for our complex family structures.

For the Indian family, whether living together in one city or spread across the globe, this combination offers something priceless: the assurance that your safety net is woven with integrity. And in matters of your family’s health, that’s the only kind of promise worth making.

Zydus Lifesciences’ US arm Sentynl secures FDA approval for ZYCUBO, first-ever treatment for Menkes disease

Aman Shukla — Tue, 13 Jan 2026 04:44:03 +0000

Zydus Lifesciences Limited has achieved a major global healthcare milestone after its wholly owned US subsidiary Sentynl Therapeutics Inc. announced that the U.S. Food and Drug Administration has approved ZYCUBO® (copper histidinate) for the treatment of Menkes disease in pediatric patients. This approval marks a historic first, as ZYCUBO becomes the only FDA-approved therapy available for this rare and often fatal genetic disorder in the United States.

The approval represents a breakthrough moment for families affected by Menkes disease, a rare X-linked recessive condition caused by mutations in the ATP7A gene. Children born with this disorder are unable to absorb and transport copper properly, particularly across the blood-brain barrier, leading to severe neurological deterioration. Until now, there had been no approved treatment option available in the US, and most untreated patients did not survive beyond three years of age.

ZYCUBO is a subcutaneous injectable formulation of copper histidinate designed to restore copper homeostasis and maintain healthy copper levels in affected patients. By addressing the underlying copper deficiency at an early stage, the therapy offers a meaningful chance to alter the disease’s otherwise devastating course. Importantly, ZYCUBO is not indicated for the treatment of Occipital Horn Syndrome.

Commenting on the development, Dr. Sharvil P. Patel, Managing Director of Zydus Lifesciences, described the FDA approval as a transformative moment for the group and the rare disease community. He highlighted that, for the first time, patients and caregivers now have access to an approved therapy, bringing hope where no viable options previously existed and reinforcing Zydus’ commitment to advancing patient-centric innovation.

The FDA’s decision was supported by strong topline clinical efficacy data. Patients who received early treatment with ZYCUBO demonstrated a statistically significant improvement in overall survival compared with an untreated contemporaneous external control cohort. The results showed nearly an 80% reduction in the risk of death. Median overall survival for patients in the early-treatment group reached 177.1 months, compared with just 17.6 months in untreated patients, underscoring the therapy’s potential to dramatically change long-term outcomes.

Matt Heck, CEO of Sentynl Therapeutics, noted that Menkes disease poses immense challenges for patients and families due to the lack of a cure and historically poor survival rates. He stated that the FDA’s approval confirms that a safe and effective therapy is now available for children living with this devastating condition.

From a safety perspective, the most commonly reported adverse reactions, observed in at least 7% of patients, included pneumonia, viral and bacterial infections, respiratory failure, seizures, hemorrhage, hypotension, vomiting, tachycardia, fever, diarrhea, anemia, elevated transaminases, dyspnea, fractures, volume depletion, and local administration site reactions. These findings were consistent with expectations in a severely ill pediatric population.

ZYCUBO was acquired by Sentynl from Cyprium Therapeutics in 2023 and subsequently advanced through the final stages of regulatory development. The therapy received multiple FDA designations, including Breakthrough Therapy, Fast Track, Rare Pediatric Disease, and Orphan Drug status, reflecting its importance in addressing a critical unmet medical need. Copper histidinate has also been granted Orphan Drug Designation by the European Medicines Agency, opening the door for potential future approvals beyond the United States.

Alembic Pharmaceuticals secures USFDA tentative approval for Bosutinib 400 mg tablets

Aman Shukla — Mon, 12 Jan 2026 06:42:18 +0000

Alembic Pharmaceuticals Limited has announced that it has received tentative approval from the US Food & Drug Administration (USFDA) for its supplemental Abbreviated New Drug Application (sANDA) for Bosutinib Tablets, 400 mg. This development further strengthens Alembic’s oncology portfolio in the highly regulated US generics market.

The approved sANDA is therapeutically equivalent to the reference listed drug Bosulif Tablets, 400 mg, marketed by PF Prism C.V.. Bosutinib is a kinase inhibitor indicated for the treatment of adult patients with Philadelphia chromosome–positive (Ph+) chronic myelogenous leukemia (CML). The therapy is used in newly diagnosed patients as well as in those who are resistant or intolerant to prior treatment. It is also indicated for adult patients with accelerated or blast phase Ph+ CML who have shown resistance or intolerance to earlier therapies.

Alembic had earlier received final USFDA approvals for Bosutinib Tablets in the 100 mg and 500 mg strengths. With the tentative approval for the 400 mg dosage, the company continues to expand the dosage coverage of this critical oncology medication, enhancing its competitive positioning in the US market.

According to data from IQVIA, Bosutinib Tablets, 400 mg, have an estimated market size of approximately US$ 251 million for the twelve months ended September 2025, highlighting the commercial significance of this approval once it converts into final clearance.

With this latest milestone, Alembic Pharmaceuticals now has a cumulative total of 232 ANDA approvals from the USFDA, comprising 212 final approvals and 20 tentative approvals.

Are Blood Pressure Watches Accurate Enough for Clinical Use?

News Desk — Tue, 23 Dec 2025 16:53:55 +0000

Blood Pressure Smartwatches Offer Convenience, but Accuracy Remains a Major Concern

Wearable health devices have become part of everyday life. Step counts, sleep scores, and heart rate alerts are now routine. Beyond heart rate, blood pressure–monitoring smartwatches seem like the next natural step, especially for people with hypertension who are on medication or who simply want to track their heart health.

The idea of checking blood pressure anytime, anywhere, without the hassle of a large cuff, is highly appealing. For many users, it feels far more convenient than sitting down with a traditional home monitor.

But convenience does not automatically translate to medical reliability. When it comes to clinical blood pressure monitoring, accuracy matters far more than ease of use.

What Major Health Organizations Say About Accuracy

Most medical organizations are cautioning people to be careful. The American Heart Association has repeatedly stated that most blood pressure measurement methods using cuff-integrated wearables are not accuratefor diagnosing or making treatment decisions.

Even though these gadgets are still far from perfect, they are being developed to improve patient care in the future. Researchers at universities are very optimistic about the day when these gadgets will be as practical as traditional blood pressure measurement methods.

Wrist-based devices are less affected by positioning and movement than upper-arm devices and smartwatch-style monitors. A slight change in wrist position can lead to a large difference in the readings. Hence, doctors consider blood pressure readings from smartwatches not equivalent to clinical measurements.

Key Limitations That Affect Clinical Reliability

The most significant problem is validation. A large number of smartwatches designed for blood pressure monitoring have failed to meet the strict testing requirements set by the AAMI, ESH, or ISO. The regulatory approval is often interpreted as a sign that the device is safe for sale, not that its accuracy is at the clinical level.

Research also highlights proportional bias. Many devices tend to overestimate low blood pressure and underestimate high blood pressure. This is one of the most critical issues. Someone with rising hypertension could be falsely reassured, while another person might worry unnecessarily about a problem that is not actually there.

Calibration is another weak point. Many cuffless devices rely on regular calibration using a traditional cuff-based monitor. If the initial measurement is off or calibration is skipped, the smartwatch readings drift further from reality over time.

Why Calibration and Technique Matter More Than Most Users Realize

Measuring blood pressure at the wrist is more complex than at the upper arm. The arteries are smaller, closer to the skin, and more affected by body position. Holding the wrist slightly above or below heart level can change the result. Movement, cold temperatures, recent exercise, and even skin characteristics can also interfere.

An easy comparison is weighing groceries. A stable digital scale on the floor gives more consistent results than trying to balance the bag in one hand. Upper-arm cuffs provide that stable reference point. Wrist-based readings require more effort and precision from the user, which is challenging to maintain in daily life.

How Consumers Should Use These Devices Safely

Blood pressure smartwatches can still be useful when used appropriately. They can help users notice long-term trends, identify patterns, and stay more engaged with their health. Seeing repeated high readings may prompt someone to seek medical advice sooner, which is a real benefit.

However, they should never replace medical guidance or clinically validated equipment. Making treatment decisions based on inaccurate data carries real risks, including unnecessary medication changes or delayed care.

Anyone considering a blood pressure smartwatch should prioritize safety. The best approach is to use a certified cuff-based monitor to obtain accurate measurements and then discuss the results with a medical professional. In blood pressure monitoring, reliability, not how modern or high-tech the device is, remains the key factor.

How Prostate Health Affects Bladder Control in Men

News Desk — Tue, 14 Oct 2025 08:22:18 +0000

In India, conversations around men’s health often shy away from sensitive topics like urinary incontinence. However, as men age, prostate health becomes an increasingly important concern, and its impact on bladder control is both real and manageable.

Whether it’s due to benign prostatic hyperplasia (BPH), prostate surgery, or other medical conditions, many men face some degree of urinary leakage or inability to control bladder function. Fortunately, this stage of life can be managed with comfort and relaxation, fostering confidence and peace of mind through increased awareness, proactive care, and discreet hygiene solutions, such as adult incontinence products for men.

Let’s examine how bladder control is impacted by prostate health and how Indian men and their families can react with compassion, understanding, and informed decision-making.

Why Does the Prostate Matter

The urethra, which is the tube that carries urine out of the body, is enveloped by the prostate, a small gland approximately 3–4 cm in diameter, situated just beneath the bladder. Benign prostatic hyperplasia, or BPH, is the term for a condition where men’s prostate glands regularly expand as they age. This enlargement can press against the urethra, leading to:

A frequent need to urinate
Difficulty starting urination
Weak or interrupted flow
A sense that the bladder hasn’t fully emptied
Urinary dribbling or leaks

Prostate Conditions That Can Impact Bladder Control

1. Benign Prostatic Hyperplasia (BPH)

A non-cancerous enlargement of the prostate that affects over 50% of Indian men over the age of 50. While not dangerous, it can cause persistent urinary issues.

2. Prostatitis

Inflammation or infection of the prostate gland can lead to painful urination and bladder irritation.

3. Prostate Cancer Treatments

Radiation or surgery for prostate cancer can temporarily or permanently affect bladder control due to nerve damage or reduced muscular support around the urethra.

Recognising Incontinence in Men

Men often associate incontinence with loss of control — but it’s essential to understand that it’s not uncommon, and not something to be ashamed of. Common signs include:

Unintentional leaks while coughing, sneezing or lifting
Night-time urination disrupts sleep
Dribbling after urination
Sudden and urgent need to pass urine

How Adult Diapers Can Help Men

Modern adult diapers for men are designed to support individuals facing urinary incontinence with dignity, discretion and comfort. They’re not just a hygiene product, they’re a lifestyle enabler.

Key Benefits:

Secure Absorption: Keeps leaks in check, especially during busy workdays or long commutes.
Contoured Fit: Designed to provide a snug fit for the male anatomy, offering enhanced protection and comfort.
Discreet Design: Slim and silent, allowing wear under everyday clothing.
Odour Control: Advanced materials neutralise unpleasant smells.
All-Day Comfort: Breathable fabric and anti-rash linings make it suitable for India’s warm climate.

Whether used daily or during specific times, such as travel or recovery, adult diapers for men help individuals regain control over their bladder management, providing a practical and convenient solution that empowers them to live their lives to the fullest.

Supporting Prostate and Bladder Health

In addition to using hygiene aids, making lifestyle changes can also have a significant impact on overall health. These include:

Stay Active: Regular physical activity enhances circulation and supports the pelvic muscles.
Kegel Exercises: Strengthen the muscles involved in bladder control.
Balanced Diet: Include foods rich in zinc, fibre, and antioxidants. Avoid excessive caffeine or alcohol.
Hydration: Sip water throughout the day instead of drinking large amounts at once.
Scheduled Voiding: Going to the toilet at set times can help reduce the urge to urinate and the likelihood of accidents.

Caring Without Judgment

In Indian households, elderly or unwell men may hesitate to speak up about bladder issues. Family members and caregivers must approach the topic with compassion, understanding, and respect, avoiding embarrassment or shame, to make their loved ones feel heard and valued. If a loved one is dealing with post-prostate surgery incontinence or facing difficulties due to ageing, offering them the right adult diapers for men can be a practical way to show care, while preserving their sense of independence.

Final Thoughts

Prostate health plays a significant role in a man’s overall well-being, and understanding its connection to bladder control is the first step towards better care. While medical guidance is essential, managing the day-to-day impact of urinary incontinence becomes much easier with the support of high-quality adult diapers for men.

They are not a sign of weakness; they are a tool for strength, resilience, and quality of life. With growing awareness and modern solutions readily available in India, men no longer need to suffer in silence. The journey to better health starts with the confidence to take the first step — and that includes the proper care, the right products, and the right mindset. If you or a loved one is struggling with urinary incontinence, consider adult diapers for men as a practical and dignified solution. Take the first step towards better bladder control today.

Mental Health Insurance Problems Continue: 5 Things To Check Before Buying a Cover

News Desk — Thu, 09 Oct 2025 17:04:13 +0000

In recent years, mental health has come to the forefront of health conversations in India. With more people acknowledging the importance of emotional well-being, the demand for insurance that supports mental health treatment has grown. However, despite regulatory efforts, mental health insurance coverage still presents several practical challenges. If you are planning to invest in a policy, it is essential to go beyond just the premiums and understand what you are really signing up for.

This blog highlights five things you must check before purchasing a mental health insurance plan.

1. Scope of Coverage

Before signing up, be clear about what mental health conditions are covered. While the Insurance Regulatory and Development Authority of India (IRDAI) has mandated that all health insurers cover mental illnesses, the actual scope of what’s covered can vary widely across insurers.

Look for:

Types of mental disorders covered (e.g., depression, anxiety, schizophrenia)
Inpatient vs outpatient care
Emergency hospitalisation due to mental health issues

Common exclusions include:

OPD consultations
Therapy or counselling sessions
Drug and alcohol rehabilitation

When comparing policies through health insurance online platforms, carefully read through the policy documents to understand the scope of coverage.

2. Hospital Network and Accessibility

Many health insurance policies list limited mental health facilities under their network hospitals. This can restrict your access to the right treatment at the right time.

Check:

Whether the insurance has tie-ups with mental health hospitals
Availability of specialists like psychiatrists and psychologists within the network
If treatment centres are located near you

A wide network ensures smoother claim processing and reduces out-of-pocket costs.

3. Waiting Periods and Pre-existing Conditions

Mental health-related claims often come with waiting periods. If you have a pre-existing mental health condition, the waiting time could be longer.

Points to verify:

General waiting period (typically 2-3 years for mental illnesses)
Specific waiting periods for pre-existing conditions
Documentation required to prove mental health conditions or past treatments

Remember, some insurers may reject claims based on undisclosed mental health history.

4. Claim Process and Support Services

Even with the best policy, a complicated claim process can leave you frustrated and financially strained. Mental health claims may require different documentation compared to physical health claims. The lack of standardised procedures across insurers adds to the confusion.

Ask the insurer:

What documents are needed for a mental health claim?
Is there a dedicated claim support team?
How long does claim settlement typically take?

Also, check whether the insurer offers additional support like

Counselling helplines
Digital health assessments
Cashless claim options

If you are also considering policies for your family, explore health insurance plans for parents that include mental health benefits.

5. Cost vs Benefits: Is It Worth It?

The last thing to assess is whether the policy offers value for money. Mental health treatments can be expensive, especially if they involve long-term care.

Check:

Annual premium vs expected cost of treatment
Co-payments or sub-limits for mental health
Add-on riders that enhance mental health coverage

Red flags:

Low premium but limited coverage
High deductibles for mental health claims
No mention of mental health in policy brochure

Conclusion

Choosing a mental health insurance plan requires more scrutiny than a regular policy. It is not just about hospitalisation or emergency care but about continuous support, fair claim settlements, and accessible mental health services.

Comparing health insurance online can provide clarity and access to the latest policy features. Additionally, if your focus is on family, particularly elderly care, consider health insurance plans for parents that include relevant mental health support.

Disclaimer: The above information is for illustrative purposes only. For more details, please refer to the policy wordings and prospectus before concluding the sales.

Step-by-Step Guide on How to Choose a Maternity Insurance Plan

News Desk — Wed, 08 Oct 2025 04:58:54 +0000

Health insurance is a contract entered into between an insurance company & an individual, where the health insurance company offers complete coverage to the insured maximum up to the limit of the sum assured. Maternity Insurance is a type of Health Insurance Plan that offers pregnancy-related expenditures, providing coverage to pregnant women or future mothers. It covers expenses for both normal & caesarean deliveries. Also, it covers both pre- & post-hospitalisation treatment costs, which include consultation fees, surgeon fees, & anaesthesia.

Reasons to Buy Maternity Insurance

It includes both pre- & post-natal delivery charges.
It safeguards the parents against rising medical costs.
It offers a cashless facility to the future parents at around 14000+ network hospitals.
It covers maternity-related pre-hospitalisation expenses up to 30 days prior to the birth of a child.
It covers maternity-related post-hospitalisation expenses up to 60 days after the birth of a child.
It covers medical expenses in both the cases of caesarean & normal delivery, along with the post-delivery complications.
It also protects a newborn from day 1 to day 90 if they are diagnosed with a life-threatening or congenital ailment.

Steps to Choose a Maternity Health Insurance Plan

Provided are the steps to be followed to buy a Maternity Health Insurance Plan:

Assess Your Requirements

1. Pregnancy Timings

When you are planning a family, it is advised to buy a health plan in advance to cover the waiting period.

2. Number of Children

In case you want to plan more than one child, consider whether your plan has any limit on the number of claims.

3. Expected Type of Delivery

Though most of the plans include both cesarean & normal delivery, still, check out the policy document to understand the applicable terms & conditions.

4. Preferred Hospitals

Go through the list of hospitals that are included in the list of network hospitals for cashless treatments.

Waiting period

In normal circumstances, there exists a waiting period ranging between 9 months & 4 years. You should consider a plan with the shortest waiting period to best align with the future financial objectives.

Sum Insured

While choosing a health plan with maternity benefits, select a plan that covers the maternity & newborn’s expenses, taking into account the impact of inflation & complications, if any.

Inclusions & Exclusions

Before buying a plan, you should evaluate the inclusions & exclusions of the plan, if any.

Check the Premium Amount

Evaluate the amount of premium offered by different insurance companies against the sum insured.

Network Hospitals

Check for the insurance company that offers an option to choose the list of hospitals in your vicinity, resulting in cashless treatment.

Claim Settlement Ratio

The term Claim Settlement Ratio refers to the percentage of claims settled by an insurance company as against the total number of claims received during a year. Always choose an insurance company with a high claim settlement ratio as they provide a better scope of claims getting settled in future.

Renewability

Consider the plan which offers an option to renew the plan at the end of its tenure to continue receiving the benefits for future pregnancies, if any.

Eligibility Criteria

One should consider the age criteria while buying a health plan with maternity benefits, which generally range between 18 & 45 years.

Compare Different Policies

Compare the different available health plans with different insurance companies, depending on different parameters, such as premium, inclusions, exclusions, waiting period, sum insured, etc.

Evaluate the Insurance Company’s Reputation & Customer Service

Conduct research on the reputation, customer service quality, & claim settlement ratio of the chosen insurance company. This can be done with the help of online reviews & ratings available on Google or any other website.

Benefits of Maternity Health Plan

Provided are some of the Benefits of Health Insurance with maternity coverage:

Effortless Experience:

Buying a health plan online avoids the hassle of paperwork or standing in long queues, etc., allowing you to purchase sitting at the comfort of home.

Tailored to You:

It allows you to customise the plan as per your own convenience, which best suits your needs.

Easy Comparison:

It allows you to compare different health plans available online using certain online tools, which helps you evaluate the premium amount, coverage amount, or any other additional benefits.

Clear Information:

The online platform is quite transparent in terms of providing crystal clear information related to coverage, premium, & other terms & conditions. It offers a straightforward process which provides the information in detail without misleading the customers.

Accessibility Round the Clock:

The online platform does not restrict itself to time, which means you can access the web portal of insurance companies 24/7. This makes it easy to access any information, raise concerns & queries, & buy the plan whenever you want.

Affordable Premiums:

These plans come with a budget-friendly premium amount, which means it is a cost-effective plan which helps save many costs when we buy it online.

Speedy Claims:

When it comes to raising a claim, the online process is very quick, speedy & efficient, which involves less paperwork & quicker approvals. It provides you with instant financial support without any delays at the critical time of delivery.

Inclusions

Delivery Expenses in the case of both Caesarean & Normal Delivery.
Pre & Post Natal expenses
Miscellaneous expenses like ventilator care & vaccinations during the first year.
30 days before hospitalisation.
60 days after discharge.

Exclusions

Doctor’s visit in case of regular health check-ups.
Consultation fees & diagnostic tests during pregnancy.
Treatment costs for premature termination of pregnancy within 12 weeks of conceiving.
Medical expenses of ectopic pregnancy.
IVF
Late pregnancies above 45 years of age.

Conclusion

A maternity health plan is a type of health insurance plan that includes hospitalisation expenses, delivery costs, medical expenses, etc. Parenthood, though, is the most beautiful journey, but it is expensive too, which is due to rising medical expenses. This makes pregnancy a financial burden, due to which people consider a maternity health plan to provide them with quality healthcare services with financial security.

PharmEasy Highlights Dengue as a Growing Monsoon Concern

News Desk — Tue, 07 Oct 2025 10:23:36 +0000

PharmEasy, a leading digital healthcare platform, has released a report titled “Dengue: The Silent Threat of the Monsoon Season”, based on an analysis of over 1.2 lakh diagnostic tests conducted across India between April 2022 and December 2024.

The report highlights a shift in testing trends, with people now seeking dengue tests as early as May—one month earlier than in previous years.

Dengue positivity rates differ across states, the report shows. Bihar (17.51%), Haryana (15.43%), and Chandigarh (15.09%) lead the chart, while Maharashtra (5.51%) and Karnataka (6.26%) remain on the lower side, reflecting the benefits of early testing and public health measures.

The findings reveal that individuals aged 11–30 are the most likely to test positive. Among patients, men under 50 showed higher positivity rates, while women above 50 were more prone to severe complications.

Most cases were reported between August and October, when high humidity (60–78%) and temperatures above 27°C created ideal breeding conditions for Aedes mosquitoes. The study also noted that Google searches related to dengue spiked in parallel with rising case numbers, reflecting heightened public concern.

PharmEasy’s article highlights the need of targeted interventions in high-incidence states, enhanced disease surveillance, and a greater focus on vulnerable groups. Suggested preventive steps include using repellents, wearing protective clothing, eliminating stagnant water, and installing window nets or screens.

As cases continue to rise, early testing and timely care remain critical in reducing complications. PharmEasy aims to raise awareness and empower individuals to take preventive steps for a safer monsoon season.

Brain Tumor Symptoms vs. Common Headaches: How to Tell the Difference

News Desk — Mon, 08 Sep 2025 05:24:00 +0000

Among the many health issues experienced globally, headaches stand out as very common. These can be caused by stress, not drinking enough water, maintaining a bad posture, and spending too much time looking at digital screens. Nonetheless, there are occasions when a continuous headache could signify a grave illness such as a brain tumor. Knowing how to differentiate between brain tumor symptoms and common headaches is important for timely diagnosis and treatment.

Understanding Common Headaches

The majority of headaches are harmless and can be classified as tension, migraine, or cluster headaches.

Dull throbbing pain is experienced on both sides of the head during tension headaches, which are usually associated with stress or muscle tension.
Migraines are intense headaches that may come with nausea, vomiting, and sensitivity to light or sound.
Cluster headaches are less common but extremely painful, often occurring around one eye.

These headaches usually respond to rest, hydration, or over-the-counter medication. In addition, they are usually precipitated by factors such as insomnia, an empty stomach, and tension.

Brain Tumour Symptoms: When a Headache Is More Than a Headache

Headaches resulting from brain tumors are different from normal headaches because they tend to have unique features and are also linked with other neurological abnormalities. Some key brain tumor symptoms to look out for include:

Headaches that worsen over time – Headaches caused by brain tumors usually get worse and are not relieved by common painkillers.
Morning headaches – These are more common because lying down increases pressure inside the skull at night.
Associated nausea and vomiting – In the absence of any other obvious cause, such as infection or food poisoning, this might serve as an alarm.
Vision changes – Increased intracranial pressure may be indicated by blurred or double vision or sudden loss of vision.
Seizures – New or unexplained seizures should never be ignored, as they can be linked to brain tumors.

Headaches are a cause for concern when they come with weakness, numbness, or problems speaking because these are signs of some neurological defects.

How to Tell the Difference

The biggest distinction is that brain tumor symptoms often come with other neurological issues, while common headaches are usually isolated. In case of a sudden change in your headache pattern, an extremely severe headache, or one that comes with symptoms such as confusion, lack of coordination, and memory lapses, seek medical attention without any delay.

Why Early Detection Matters

Brain tumors may be benign (non-cancerous) or malignant (cancerous), but both can affect brain function if untreated. The probability of successful treatment is higher when cancer is detected early and treated with surgery, radiation, or targeted therapy. Failure to take note of abnormal headache patterns may prolong diagnosis and give rise to further complications.

When to See a Specialist

Seek medical attention if you experience:

Headaches that are constant and do not get better even after taking a break or some drugs.
Fresh signs of a nervous system disorder, such as vision complications, fits, or inability to speak properly.
Headaches with mysterious vomiting or aggravation in the morning.

To find out the root of the problem, a neurologist or neurosurgeon may advise imaging tests, such as MRI or CT scans.

Conclusion

Not every headache is a sign of a brain tumor, but being aware of brain tumor symptoms can help you take timely action. The best thing to do would be to consult a specialist if there are strange headache occurrences with other neurological symptoms that you or your family member may experience. Early diagnosis and timely interventions can help combat brain tumors effectively.

5 Components that influence IVF success

News Desk — Fri, 18 Jul 2025 05:19:15 +0000

Watching while waiting for your family is the dream of every ordinary married couple. Most people wish for this, which is one of the things that mostly happens; moreover, one of them faces numerous issues with the method of conception. This is particularly problematic when they are unable to conceive, which can be a notably significant issue. When one individual is significantly outside the fertility period, the reality of the situation is that they can also experience the problem if they either sit back and hope for miraculous solutions or take charge of their fate by consulting the best IVF centre in Punjab.

Getting help from one of the clinics close to you will be a constructive way that not only can you address the root of your infertility issues, but also you can make sure that you’re capable of having help with. With the procedure, if you can go through it, but if it is not well managed, there are all the complications of conception that an individual might encounter. Let’s delve into the details and discuss the benefits of an influential IVF success.

Duration of Intended Guardians: One of the core components that can enhance IVF success is a lifetime relationship. The bigger the individual or the guardians are. The larger an individual is, the lower the opportunity of success at conception and, therefore, the IVF procedure. If one is having problems with conception, it is suggested that one undergo IVF as soon as possible.
Better Reproductive Cells: Building on the previous point, it is equally essential to ensure the best of both sperm and eggs. For optimal outcomes, individuals should strive to maintain the highest standards of reproductive health.
Good Embryo Development: IVF success also significantly determines the quality of the embryo developed after the fertilisation procedure. The success of the procedure directly hinges on the fact that one can have thoroughly well-formulated embryos with no deformities .
Knowledge and Proficiency in Fertility Clinic : The success can also entirely depend on the experience of the fertility clinic you have chosen. The more successful cases a clinic has, the more you can rest assured that you will be able to achieve success as well.
Examine Lifestyle Factors and Overall Health: The ultimate factor that impacts IVF success is the recent lifestyle and health of both male and female partners. The healthier one is, the better the chances of success one can have.

Conclusion

Suffering through an infertility condition can prove to be an entirely disconcerting experience when all one wants is to start a family or to expand one’s existing one. It can be challenging to make sure that one is thoroughly able to conceive and have a healthy pregnancy. If one has this unexplained infertility, one can seek help entirely from an assisted reproductive technology. With the IVF method, one can notably improve the process of conception and the chances of victoriously having a baby.

Cancer Treatment Gets a Boost with Radixact System in Mumbai

Riddhima Jain — Tue, 01 Jul 2025 11:21:11 +0000

A Mumbai hospital has introduced the Radixact® Treatment Delivery System, a new radiation therapy technology aimed at improving accuracy in cancer treatment and reducing harm to healthy tissue.

The system combines real-time imaging with adaptive targeting, allowing doctors to adjust radiation delivery as the patient’s body moves—such as during breathing. A built-in CT scanner helps ensure the tumor remains accurately targeted throughout the procedure.

According to the hospital, this upgrade is part of ongoing efforts to improve cancer care through more precise, individualized treatment. The system is capable of treating a variety of cancers and is designed to deliver higher doses of radiation with fewer side effects.

The hospital has also invested in genomic testing and precision oncology infrastructure. A 500-gene cancer panel is being used to support more tailored treatment plans based on a tumor’s genetic profile.

precision and efficiency.

Dr Santosh Shetty, Executive Director and CEO of Kokilaben Dhirubhai Ambani Hospital & Medical Research Institute said, “At Kokilaben Hospital, we are constantly pushing the boundaries of medical innovation to ensure our patients receive the most advanced and effective treatment. The adoption of the globally acclaimed Radixact® system marks a major leap forward in our commitment to delivering world-class cancer care. As a centre that continues to be recognized for its leadership in oncology, we are proud to bring one of the most sophisticated radiation technologies to India. This upgrade reaffirms our dedication to adopting global standards that improve both clinical outcomes and quality of care.”

The adoption of the Radixact system comes amid a growing cancer burden in India. Health experts say timely access to accurate diagnosis and targeted treatment remains a challenge for many patients, and that such technologies could help improve survival rates and reduce complications.

Best Fertility Doctor in Delhi: Your Guide to Choosing the Right Specialist

News Desk — Wed, 25 Jun 2025 17:52:02 +0000

The journey toward parenthood is deeply personal and often filled with anticipation, hope, and a fair share of challenges. For many individuals and couples in Delhi, seeking the support of a fertility specialist is a significant and empowering step. Choosing the best fertility doctor in Delhi can make all the difference, providing not only medical expertise but also emotional reassurance and a sense of partnership along the way.

Why Delhi is a Preferred Choice for Fertility Treatment

Delhi has emerged as a leading destination for fertility care in India. The city is home to some of the country’s most advanced fertility clinics, equipped with the latest technology and staffed by highly qualified specialists. Patients from across India and abroad are drawn to Delhi for its blend of medical excellence, accessibility, and comprehensive care.

The best fertility doctor in Delhi offers more than just clinical skills. They understand the emotional complexities involved in fertility treatment and provide compassionate guidance at every stage. Whether you are considering treatments like IUI (Intrauterine Insemination), IVF, or exploring options for fertility preservation, finding the right specialist is key to a positive experience and optimal outcomes.

What Makes a Fertility Doctor “The Best”?

When searching for the best fertility doctor in Delhi, there are several important qualities to consider. While medical credentials are crucial, the right specialist should also embody empathy, patience, and a commitment to personalised care.

Experience and Qualifications: Look for a doctor with extensive experience in reproductive medicine and a track record of successful outcomes. Board certifications, specialised training, and ongoing education in the latest fertility techniques are all indicators of a dedicated professional.
Clear Communication: Fertility treatments can be complex and require clear communication. The best fertility doctor in Delhi will take the time to explain each step, answer your questions, and ensure you feel comfortable and informed. They should be approachable and willing to discuss all available options, including IUI, IVF, and other advanced therapies.
Individualised Approach: Every fertility journey is unique. A top specialist will tailor treatment plans to your specific needs, taking into account factors such as age, medical history, and personal preferences. They will also respect your values and decisions at every stage.
Supportive Team: Behind every great fertility doctor is a team of caring professionals, including embryologists, nurses, counsellors, and support staff. A collaborative environment enhances the quality of care, ensuring you receive comprehensive support throughout your treatment.
Focus on Emotional Well-being: Fertility challenges can be emotionally taxing. The best fertility doctor in Delhi recognises the importance of mental health and offers access to counselling and support groups. This holistic approach helps you stay resilient and hopeful.

Understanding Fertility Treatments: IUI and Beyond

One of the most commonly recommended fertility treatments is IUI, or Intrauterine Insemination. This procedure involves placing prepared sperm directly into the uterus during ovulation, increasing the chances of fertilisation. IUI is often suggested for couples with unexplained infertility, mild male factor infertility, or issues related to cervical mucus.

In addition to IUI, Delhi’s fertility clinics offer a full spectrum of assisted reproductive technologies, including:

IVF (In Vitro Fertilisation): Eggs are fertilised with sperm in a laboratory, and the resulting embryo is transferred to the uterus.
ICSI (Intracytoplasmic Sperm Injection): A single sperm is injected directly into an egg, often used for severe male infertility.
Egg and Sperm Donation: Donor gametes are used when one partner cannot provide viable eggs or sperm.
Surrogacy: An option for individuals or couples unable to carry a pregnancy themselves.
Fertility Preservation: Egg or sperm freezing for those who wish to delay parenthood.

Your fertility doctor will guide you in selecting the most appropriate treatment based on your diagnosis, preferences, and goals.

Questions to Ask During Your Consultation

Meeting a fertility specialist for the first time can feel overwhelming. To make the most of your consultation, consider preparing a list of questions such as:

What diagnostic tests will you recommend, and why?
What are the treatment options available for my specific situation?
What are the success rates for IUI or other treatments in your clinic?
How will you personalise my treatment plan?
What emotional support services are available?
Are there any potential risks or side effects I should be aware of?
What are the costs involved, and are there payment plans or packages?

A good fertility doctor will welcome your questions and answer them with clarity and patience.

The Importance of a Supportive Environment

Fertility treatment is not just about medical procedures; it’s about feeling supported and understood. The best fertility doctor in Delhi will foster an environment where you feel respected, heard, and cared for. This includes transparent communication, regular updates on your progress, and encouragement to share your concerns or fears.

Many clinics in Delhi offer additional services such as nutritional counselling, stress management workshops, and peer support groups. Utilising these resources can help you maintain a positive outlook and enhance your emotional well-being throughout your journey.

Practical Tips for Choosing the Right Specialist

Research and Reviews: Read patient testimonials and independent reviews to get a sense of the doctor’s reputation and approach.
Visit Multiple Clinics: If possible, schedule consultations with more than one fertility specialist to compare their perspectives and treatment philosophies.
Trust Your Instincts: Pay attention to how you feel during your interactions. The right doctor should inspire confidence and make you feel at ease.
Consider Logistics: Location, clinic hours, and ease of communication are practical factors that can influence your experience.
Ask About Success Rates: While no doctor can guarantee results, understanding the clinic’s track record can help set realistic expectations.

Final Thoughts

Choosing the best fertility doctor in Delhi is a meaningful step on your path to parenthood. Remember, you deserve compassionate, expert care that addresses both your physical and emotional needs. Take your time, ask questions, and trust yourself to make the decision that feels right for you.

The road to building a family may have its ups and downs, but with the right support and guidance, hope can flourish. Whether you are just starting to explore fertility treatments or have been on this path for some time, know that you are not alone. Delhi’s fertility specialists are dedicated to helping you achieve your dream, one step at a time.

The Impact of Medical Expenses on Financial Goals

News Desk — Wed, 11 Jun 2025 15:03:48 +0000

You never know when a medical emergency may arrive, exhausting your savings and financial planning. Considering the increasing healthcare costs in India, it is essential to get health insurance for you and your family. It can safeguard you from a significant financial need that may arise due to sudden medical conditions.

You can buy health insurance online without dealing with any insurance brokers to manipulate your decision.

However, before getting health insurance, you must understand the impact of healthcare expenses on your long-term financial goals. This will help you choose the right policy that aligns with your financial and health needs.

How Medical Expenses Can Affect Your Financial Goals?

Here are some of the ways medical expenses are affecting your financial goals:

● Exhausting Your Savings and Investments

A medical emergency can drain your savings and investments, which were kept aside for financial goals like children’s education, buying a house, retirement, etc. With rising medical costs, even routine health checkups like medicines, doctor visits, and minor diagnostic procedures can exceed your monthly budget. This will affect your savings and investments for the future.

● Increasing Debt Burden

High out-of-pocket medical costs can result in debt if proper planning isn’t done. Many families turn to credit cards or personal loans to pay for long-term treatments, surgeries, or hospital bills. This affects your creditworthiness and long-term financial health, increasing your financial stress and taking money away from wealth-building endeavours to pay off debt.

● Disrupting Your Retirement Planning

Medical inflation and the increased likelihood of health issues with age mean that retirees often face higher healthcare costs. If these are not planned for, you may need to dip into your retirement savings, jeopardising your financial independence and standard of living during your golden years.

● Affecting Family Finances

Medical emergencies don’t just impact individuals—they can affect entire families. Caring for ageing parents or dependents with chronic illnesses can introduce new financial challenges, requiring you to reallocate resources and potentially delay or scale back personal financial goals.

● Psychological Stress

The financial strain from medical expenses can also take a toll on mental health, leading to anxiety and reduced productivity. This, in turn, can further impact your earning potential and overall financial well-being.

How Can the Right Health Insurance Policy Help?

The right health insurance policy acts as a financial safety net. It shields you from rising medical costs and helps you stay on track with your long-term financial objectives in the following ways:

● Comprehensive Coverage for Medical Expenses

Health insurance covers a wide range of healthcare costs, from routine checkups to major surgeries and long-term treatments. By paying a regular premium, you protect yourself and your family from sudden, significant expenses that could otherwise derail your financial plans.

● Cashless Treatment and Quality Healthcare

Most health insurance policies offer a network of hospitals where you can avail of cashless treatment. This means you don’t have to pay upfront and wait for reimbursement; the insurer settles the bill directly with the hospital, ensuring timely care without financial stress.

● Protection Against Medical Inflation

Medical costs are rising faster than general inflation. Health insurance helps you keep pace with these increases, so you don’t have to dip into your savings or investments to pay for expensive treatments.

● Preventive Care and Early Detection

Modern health insurance plans include preventive healthcare benefits like annual checkups, screenings, and vaccinations. Early detection can prevent larger health issues and expenses down the line, preserving your financial resources.

● Tax Benefits

Under Section 80d of the Income Tax Act, premiums paid for health insurance policies are eligible for tax deductions of up to ₹25,000 per year. For senior citizens, the deduction limit is up to ₹50,000 annually, providing additional financial relief and incentivising prudent planning.

Tips to Buy the Right Health Insurance Policy

Selecting the right health insurance policy is necessary to maximise your financial protection. Here are some of the tips that you can follow while selecting a health insurance policy:

1. Assess Your Needs and Budget

Start by evaluating your current health status, family medical history, and potential future healthcare needs. Then, consider the number of dependents, pre-existing conditions, and your premium budget.

2. Compare Plans Online

Buy health insurance online to access various policies, compare features, and read customer reviews. Online platforms often provide detailed information on inclusions, exclusions, and claim processes, helping you make a transparent decision.

3. Use a Health Insurance Premium Calculator

A health insurance premium calculator helps estimate your premium based on age, coverage amount, and policy type. This allows you to balance affordability with adequate coverage and avoid being underinsured.

4. Check Coverage and Exclusions

Go through the policy document carefully to understand the inclusions and exclusions. Look for coverage of hospitalisation, day-care procedures, pre- and post-hospitalisation expenses, and critical illnesses. Pay attention to waiting periods, sub-limits, and co-payment clauses.

5. Prefer a Cashless Hospital Network

Choose a policy with a wide network of cashless hospitals near your residence or workplace. This ensures you can access quality care without worrying about arranging funds in an emergency.

Insurers like Digit Insurance provide access to an extensive cashless hospital network across India, making it easier to receive timely treatment without financial strain. Additionally, Digit Insurance reported over 90% cashless claim processing and real-time claim updates via WhatsApp in their latest Transparency Report, ensuring that you get timely coverage and minimal out-of-pocket spending.

6. Opt for Family Floater Plans

For individuals having dependents, a family floater plan can offer comprehensive coverage for all members under a single policy, often at a lower premium than individual plans.

7. Consider Buying Add-Ons and Riders

Depending on your needs, you can enhance your coverage with add-ons like critical illness coverage, maternity benefits, or personal accident riders. You can buy this additional coverage by paying a nominal extra charge on top of your monthly premium for comprehensive health insurance.

8. Review Claim Settlement Ratio and Customer Service

A high claim settlement ratio and responsive customer service are indicators of a reliable insurer. Check these metrics before making your final choice.

Medical expenses can profoundly impact your long-term financial goals, from exhausting savings and increasing debt to disrupting retirement plans and overall family well-being. Planning for healthcare costs wisely and choosing the right health insurance policy can safeguard your financial future and focus on achieving your dreams.

You can buy health insurance online and use tools like a premium calculator to find a policy that fits your needs and budget.

Planning Ahead: Why the Right Medical Coverage Matters in Your Golden Years

News Desk — Mon, 02 Jun 2025 15:33:02 +0000

As the years pass, health issues become a regular thing that needs attention and care. What once were rare health conditions for younger people can now become more frequent, leading to regular consults, diagnoses, treatments as well as in some cases, hospitalization. In such a scenario, financial readiness is of the essence just as much as medical care is. Good medical coverage in your later years not only protects you from rising healthcare expenses but also provides peace of mind in what may be considered an unpredictable phase of life.

The Emergence of Age-Specific Health Care Needs

The rate of older people with chronic diseases is higher. Type 2 diabetes, high blood pressure, heart diseases, or respiratory problems are the most common of these conditions. At the same time, even ordinary infections may not stay that way for long and become harder to treat due to the slower healing process and the weakening of the immune system. Although regular preventive check-ups and care are effective, the probability of hospitalization, surgeries, or taking medication for an extended period is still high. To deal with these potential disasters, it is essential to have a specific and concentrated medical and financial plan for seniors.

All-embracing and Alternatives Besides Hospital Care

Current medical insurance contracts are not limited to hospital bills only. They typically cover the pre- and post-hospitalization expenses, outpatient consultations, regular check-ups, and a wide spectrum of medical treatments ranging from Ayurveda to Homoeopathy. This wider range of services not only ensures that the patients can be treated at the medical center ahead of any condition that may get worse or turn out to be an emergency, and reduces the part that an individual has to pay from his/her own pocket; an amount that could be burdensome to retirees.

Access to Quality Treatment Throughout India

Healthcare networks now have a broader reach and have connected with the majority of insurance companies that provide the facility to over 10,000 hospitals wherein the service is available throughout the nation. This vast economic range allows anyone to find a hospital cashless network near to their place no matter whether it is a metropolitan city or tier-two town. Senior citizens and their dependents are also served by quick authorisations, emergency admissions, and a 24/7 support team which further simplifies the process for them.

Senior-Friendly Plan Characteristics

It is mentioned in the plans that benefit the elderly that additional benefits are provided by the insurance that go with the changes in their health needs. For instance, patients might be given higher limits for the number of consultations, insurance for age-related mental health disorders, and in some cases, there is no ceiling for renewals. Before a certain age, some insurance covers may be purchased without a medical test being required which will make the start without the extra stress and the document delay.

Handle the Expenses Sensibly

Senior medical cover is highly anticipated but also a tad expensive. However, while a person’s age may make the premiums slightly increase, there is a big focus on ensuring not only the aged are catered for but everyone as many players now offer instalment plans, family floater plans, and even loyalty discounts with longer tenures. Moreover, for premiums paid, the Indian government gives a tax rebate, a situation that enables people to deduct the percentage of their premiums that, as a result, leaves yearly budgets intact and also encourages the purchase of more cover.

1) How many hospitals do insurance providers get access to thanks to the expansion of healthcare networks in India? – Over 10,000.

2) Give an example of some of the features of health plans that are particularly elderly-oriented. – Coverage for in-home care and travel expenses, and these insurances have no age limits or medical examinations.

3) What is the highest concern regarding senior citizens’ medical expenses? – Affordability.

4) Is it still possible to get the premiums down through one of the options such as reduced family cover, installment-based or prolonged payment, or tax rebate?

5) What is the principal area of concern regarding the senior citizens’ medical insurance affordability?

A rather disregarded yet very important part of old people’s care is the quick response to sudden events. Some of the new policies, for example, have emergency ambulance services that are specifically for the policyholder’s use, whether by air or road, which transfer the patient to the nearest comprehensive medical facility. These services have maximum benefits per incidence, but they usually provide direct claim settlements if the hospitalization is confirmed.

Personalized plans for senior years of life without disturbances

As inflation has boosted medical expenditures, people above 60 are encouraged to find options made entirely for them. These options often include outpatient procedures, one-time-a-year check-ups, AYUSH coverage, as well as aid for treatment of commonly-occurring diseases among seniors. In the unavailability of customized benefits, the purchase of off-the-shelf coverage for the elderly might result in policy exclusion, reduced refund, or even rejection of requests for age-related diseases.

A health insurance calculator is one of the most important aids in comparing plans. This instrument empowers the potential policyholder to examine premium amounts vis-à-vis benefits offered, thus enabling them to make a wise choice based on their historical health data and expected needs. However, despite calculators simplifying, they still do not account for all the details, but they are a quick way of jumping to the decision that suits the customer.

Working as a private insurer employee, a man can get the idea that his company-sponsored health plan or insurance policy is satisfactory and that it will also cover the healthcare requirements post-retirement. However, group policies may lack a personal touch or may not be suitable for senior care. Consequently, once a person retires, this type of insurance is no longer available, which necessitates finding other options where you can fill in these gaps, therefore, in the overlook; these options offer not only continuity but also flexibility.

When Family Support Alone Doesn’t Help Enough

Very often, despite the altruism and affection of their children or other family members, sick and elderly people face financial problems as a result of medical treatment. Carrying out diagnostic tests, taking a second opinion, an extended hospital stay, or after-surgery rehab are all real bank account busters. The elderly who store money in different places and have insurance plans lose their independence, they are not an unnecessary burden for anyone and lead a dignified life.

Governmental Affirmation and Policy Adjustment

It has been emphasized to the health and insurance industry that the rapid increase in the elderly population is an issue that demands a new approach in dealing with. Insurance companies that are in association with appropriate federal agencies have turned to measures that create environments wherein everyone is secure in the knowledge of getting services that respond to their personal needs. The change of the rules to allow the elderly to continue to insure once they have reached 60 years is a great benefit to the people and the fallacy of stoppage at the end of a particular age is somewhere down the road.

Insurers offering health insurance for senior citizens are playing a major role in the nation’s investment in medical security, as well as psychological welfare. Plans intended for the elderly now come with the availability of AYUSH, annual health check-ups, critical illnesses protection, and the facility of post-discharge benefits being extended that are very much aimed at satisfying just those needs of theirs.

Conclusion

One’s fulfilling one’s old age years in a state of complete harmony, dignity, and just knowing the help is there when it is needed the most is enough. The period we live in is particularly characterized by the consistent rise in healthcare costs and the strong possibility of age-related ailments occurring more frequently. At times it happens that covering late in their life is not only a wise financial decision but is also a sympathetic one for those individuals who need help. You can go over the process with your family members, and in doing so, they will understand your feelings and perhaps also help you come up with the right decision.

Marksans Pharma’s UK subsidiary Relonchem gets UKMHRA nod for Gabapentin oral solution

News Desk — Thu, 15 May 2025 03:56:30 +0000

Marksans Pharma Limited announced on May 15 that its wholly owned UK subsidiary, Relonchem Limited, has received Marketing Authorization from the UK Medicines and Healthcare Products Regulatory Agency (UKMHRA) for Gabapentin 50 mg/ml oral solution.

The regulatory approval marks a significant addition to the company’s neurology-focused portfolio in the UK market. Gabapentin is commonly prescribed for the treatment of nerve pain and epilepsy.

Marksans Pharma, headquartered in Mumbai, is engaged in the research, manufacturing, and marketing of generic pharmaceutical formulations. Its facilities in India, the US, and the UK are approved by major global regulatory bodies including the USFDA, UKMHRA, and TGA Australia. The company’s portfolio spans key therapeutic areas including cardiovascular, central nervous system (CNS), anti-diabetics, pain management, gastroenterology, and anti-allergy segments.

Disclaimer: This article is for informational purposes only and does not constitute investment advice. Please consult your financial advisor before making any investment decisions.

AIIMS Bhubaneswar cancels all staff leave amid emerging national situation

News Desk — Sat, 10 May 2025 02:14:42 +0000

In view of the evolving national situation, the All India Institute of Medical Sciences (AIIMS), Bhubaneswar has issued a directive cancelling all kinds of leave for its employees, including vacation and station leave, with immediate effect.

According to the office order dated May 9, 2025, issued under the approval of the Ministry of Health & Family Welfare, no leave of any kind will be granted to officers, except on medical grounds, until further orders. The directive applies to all faculty members, residents, and other staff, including those who are currently on leave.

“Officers who are already on leave are directed to report back to duty immediately,” the circular states, citing the need for full workforce readiness in light of the impending situation flagged by the central government.

AIIMS Bhubaneswar announced cancellation of all kinds of leave, including vacation and station leave in view of emerging circumstances. pic.twitter.com/4ydoFagWY5

— ANI (@ANI) May 10, 2025

The move comes amid heightened national alert following recent defence and security developments.

The order is now in force across the institution and was issued with the approval of the competent authority at AIIMS Bhubaneswar.

Zydus gets USFDA nod for generic version of Copaxone for treatment of Multiple Sclerosis

News Desk — Thu, 08 May 2025 17:17:30 +0000

Zydus Lifesciences Limited announced on Thursday that it has received final approval from the United States Food and Drug Administration (USFDA) for its Glatiramer Acetate Injection, a generic version of Copaxone® in 20 mg/mL and 40 mg/mL strengths.

The injection, developed in collaboration with Italy-based Chemi S.p.A., will be manufactured entirely in Europe and is indicated for the treatment of relapsing forms of Multiple Sclerosis (MS), including clinically isolated syndrome, relapsing-remitting MS, and active secondary progressive disease in adults.

The product has been classified as an AP-rated substitutable generic, making it an approved alternative to Copaxone®, which recorded annual sales of USD 719 million in the U.S. market as of March 2025, according to IQVIA data.

“This approval underscores Zydus’ leadership in bringing complex, differentiated generics to market,” said Dr. Sharvil Patel, Managing Director of Zydus Lifesciences. “Together with Chemi, we are proud to expand access to this important therapy.”

Punit Patel, President & CEO of Zydus Pharmaceuticals USA Inc., added that the approval “showcases our expertise in developing complex medications and reinforces our dedication to providing accessible, high-quality healthcare solutions.”

With this approval, Zydus now has a total of 426 final ANDA approvals out of 492 filings since the beginning of its regulatory submissions in FY2003-04.

Alembic Pharma gets USFDA final nod for Ticagrelor 90 mg, tentative approval for 60 mg

News Desk — Fri, 02 May 2025 07:59:59 +0000

Alembic Pharmaceuticals Limited announced on May 2, 2025, that it has received final approval from the US Food and Drug Administration (USFDA) for its Ticagrelor Tablets, 90 mg, and tentative approval for Ticagrelor Tablets, 60 mg.

The 90 mg dosage has been approved as a therapeutically equivalent generic to AstraZeneca’s Brilinta, and is indicated to reduce the risk of cardiovascular death, myocardial infarction (MI), stroke, and stent thrombosis in certain high-risk patients. The 60 mg variant has also received tentative approval pending patent expiry or exclusivity clearance.

Alembic was among the first ANDA applicants to file for the 90 mg dosage with a Paragraph IV certification, indicating it is contesting the innovator’s patent.

According to IQVIA data, the estimated market size in the U.S. for the 90 mg Ticagrelor tablets is approximately US$ 1,062 million, and for the 60 mg tablets is around US$ 242 million, for the twelve months ending March 2025.

With this development, Alembic’s cumulative USFDA approvals now stand at 222 ANDAs, comprising 197 final approvals and 25 tentative approvals.

The company reaffirmed its long-standing focus on regulated markets, with robust R&D and vertically integrated manufacturing capabilities. Alembic continues to expand its presence in global generics with a strong pipeline and established regulatory track record.

5 ways to embrace Menopause with confidence

News Desk — Wed, 23 Apr 2025 01:56:06 +0000

Menopause can feel unsettling, off-putting, and shocking if it hits you all at once. And sometimes, it does indeed hit all at once. Suddenly, you have new aches and pains, you’re overwhelmed by a hot flash, and you’re irritable. These changes, and more, might start to make you feel helpless, vulnerable, and (gasp) old. But the reality is menopause can be an amazing transition into your wisdom years. Here’s how to face that transition with confidence:

1. Take Care of Your Immediate Health Needs

No matter how positive you are, and how relentlessly optimistic about the future, it’s near impossible to be confident if you’re in pain. And yes, due to the hormonal fluctuations that come with menopause, many women experience discomfort and pain. Whether it’s joint pain, vaginal dryness, migraines, or frequent UTIs, you deserve relief. Before you can hope to embrace the next stage of your life, you must take care of your immediate health needs.

At times, getting relief can be a conundrum. You need to get good sleep to support your changing body, but you can’t sleep because you’re in pain. So, the first step is to take preventative measures into your own hands. Use vaginal moisturizers to help combat vaginal dryness or take a daily UTI supplement to help you get ahead of UTIs. Do what you need to get your equilibrium on a good track. Taking these initial proactive steps can help set the stage for long-term confidence.

2. Engage in Vigorous Exercise Most Days of the Week

There are few things more confidence-building than exercise. The unfortunate element, however, is that the less you exercise, the more tired and lethargic you are likely to feel. Furthermore, the less you exercise, the more the aches and pains of menopause are likely to affect you. Also, the more likely you are to develop health conditions like osteoporosis, which hits women particularly hard due to the drop in estrogen during menopause.

You can offset those health conditions and increase your energy by exercising more. In most cases, daily walks and light weightlifting can have a huge impact on your health in the best ways. But, if you’re looking for confidence, look for opportunities to exercise vigorously. This means jogging, cycling, swimming, aerobics, and, of course, heavy weightlifting. Within just a few weeks, you’ll find yourself holding your head higher.

3. Find the Others

One of the hardest parts of menopause for women’s mental health is the feeling of isolation and loneliness. Your husband can’t relate, and neither can your kids. Maybe your mother has been through it, but she’s not going through it now. This leaves you feeling misunderstood and can exacerbate feelings like anxiety, stress, and depression. Like with most conditions, the longer they’re left to fester, the worse they get.

You can turn those feelings of isolation and loneliness around quickly by finding other women going through menopause. Being in good company can remind you that there are millions of women going through what you’re going through. Join or form a book club, an exercise class, or a walking club. Get together for commiseration sessions and spa days. Friendship is an incredible medicine that will make you feel strong and confident in no time.

4. Laugh and the World Laughs with You

Here’s the thing about sadness, misery, and self-pity: you’re often alone in those feelings. People will see you having those experiences and avoid you at all costs, eventually fulfilling your feelings of being lonely and isolated. It’s a natural human response to want to avoid negative experiences in the hopes of avoiding being infected by them. While misery may love company, company does not love misery. And misery does not beget confidence.

So, you will have to turn it around and move yourself into a more positive, joyful space to attract “the others” and boost your confidence. You can engage in meditation, talk to a therapist, and, of course, exercise, which will elevate your mood. But also: watch funny videos, go to comedy shows, and work on seeing the hilarious side of life. The smile you wear will become your signature look, and it’s a sure pathway to feeling confident.

5. Eat the Cake and Drink the Wine

Finally, let go a little. Later in life, doctors, nutritionists, and many other people in the world of influencers and coaches will tell you all the things you shouldn’t be doing. And, sure, they’re not wrong. You shouldn’t be drinking to excess or devouring entire pizzas or sheet cakes in a single sitting. But, you also don’t want to hyper-fixate on your health so much that you take the joy out of life.

Unless you have a problem with alcohol or a condition like diabetes, let yourself live a little. Have the glass of wine with your girlfriends at the spa. Eat the cinnamon roll at Sunday brunch. Crack open your favorite Ben & Jerry’s every once in a while. Yes, you want to be healthy, but that doesn’t mean you can never treat yourself. Find the balance between focusing on exercise and nutrition and indulging when you’re called to. Your confidence will surely skyrocket when you feel in control of your journey.

In the end, there are many ways to embrace your menopause journey with confidence, and much of it has to do with self-care. Exercise, eat good food, find good friends, take care of your health concerns, and stay active in general. Menopausal and postmenopausal women still have so much to give to the world. And the world needs you to be strong, healthy, happy, and confident. You’ve got this.

Is diabetes treatment covered by insurance?

News Desk — Fri, 28 Mar 2025 05:37:55 +0000

Diabetes is a long-term illness affecting millions of people worldwide. It is a chronic disease that arises when your blood sugar (glucose) is too high. It can be caused by the body not producing enough insulin or not using insulin properly. Insulin is a hormone that regulates blood glucose. Hyperglycaemia, also called raised blood glucose, is a common effect of uncontrolled diabetes and over time leads to serious damage to body systems.

Managing diabetes involves regular medical care/ check-ups, diet, exercise, medications, lifestyle adjustments, and many more. Many people wonder whether their health insurance covers diabetes treatment or not. The good news is that most health insurance policies do provide the best health insurance policy for diabetic patients, but the extent of coverage depends on the specific policy.

Symptoms of diabetes might occur suddenly. Individuals with diabetes have a higher risk of health problems, including heart attack, stroke, and kidney failure. In type 2 diabetes, the symptoms can be mild and can take years to be noticed.

Some symptoms are as follows:

Feeling thirsty
Urinary frequency
Unintentional weight loss
Blurred/Hazy vision
Infections (especially gum, skin, and vaginal infections)
Numbness in hands and feet

Understanding Health Insurance policy for diabetic patients

Diabetes is a frequent ailment that affects people of all ages. There are multiple forms of diabetes. It can give rise to blindness, kidney failure, heart attacks, stroke, and lower limb amputation. The best health insurance policy for diabetic patients typically covers the cost of hospitalization, medications, and diagnostic tests. The level of coverage depends on aspects such as the type of policy, pre-existing conditions, waiting periods, and exclusions.

Essential components of Diabetes Coverage:

Medical Expenses: Many health policies offer hospital stays related to diabetes complications, such as diabetic ketoacidosis, foot ulcers, and cardiovascular issues.
Coverage for OPD Coverage: Most of the policies cover doctor consultations, diagnostic tests, and medications for diabetes management.
Pre-existing Condition Coverage: If you are diagnosed with diabetes before buying a policy, the insurer may impose a waiting period before covering diabetes-related expenses.
Critical Illness add-on: Some policies cover complications, especially kidney failure, heart disease, or stroke.
Daycare Procedures: Treatments like dialysis, insulin pump therapy, etc, can be covered under daycare procedures in select policies.

Best Health Insurance Policy for Diabetic Patients

Finding the best health insurance for diabetics in India requires evaluation of features, coverage, waiting periods, exclusions, and premium costs.

Star Health Diabetes Safe Policy – This is a health insurance policy from Star Health and Allied Insurance Company Limited that covers diabetes and its complications. It is specially designed for individuals with diabetes and available for people with Type 1 or Type 2 diabetes between the ages of 18 and 65.

Features:

Diabetes Cover: Specially tailored for individuals diagnosed with type 1 and type 2 diabetes.
Enrolment Age: Individuals aged between 18 and 65 years.
Type of Policy: This policy can be availed either on an Individual or Floater basis. The floater basis is only for a family of 2 members.
Customizable Plan: Flexible Plan With pre-acceptance medical examination or without pre-acceptance medical examination.
Elements to keep in mind while selecting Diabetes Health Insurance:
Pre-existing Disease Waiting Period: Before choosing any policy, check the waiting period before diabetes-related expenses are covered.
Coverage for OPD and Medicines: Confirm the policy covers the cost of insulin, medications, and regular check-ups.
Premium Affordability: Compare premiums across different policies to find the most cost-effective option.
Wellness Benefits: Some insurers provide incentives for maintaining a healthy lifestyle.
Lifetime Renewability: A policy with lifetime renewability guarantees uninterrupted coverage throughout your entire life.

Type 2 diabetes health insurance

Type 2 diabetes health insurance is the most common form of diabetes-related insurance and requires long-term necessities. Type 2 diabetes health insurance is widely accessible, but it comes with firm conditions and limitations.

Coverage Options for Type 2 Diabetes Patients:

Standard Health Insurance Plans: These may cover diabetes treatment after a waiting period of 24 months to 48 months.
Diabetes-Specific Policies: Specially designed for diabetic patients. These plans may offer immediate coverage for diabetes-related problems.
Health Insurance for Group: Some employers offer group health insurance with diabetes coverage for employees.

3.Type 1 Diabetes Health Insurance

Type 1 diabetes health insurance is specifically tailored for those with type 1 diabetes, an autoimmune condition that needs lifelong insulin therapy and routine checks. Selecting type 1 diabetes health insurance can be tough, but multiple policies cater to this need.

Coverage Options for Type 1 Diabetes Patients:

Diabetes-Specific Health Insurance Plans: Policies like Star Health Diabetes Safe provide coverage for type 1 diabetes health insurance patients.
Employer Group Insurance: Some employers include type 1 diabetes health insurance in group health policies.
Government Schemes: Certain public health programs offer coverage for insulin therapy and diabetes-related complications.

Conclusion

Handling diabetes can be financially incredibly challenging, but opting for the right health insurance at the right time can protect you from draining away your savings. Many companies offer tailored plans for diabetic patients, when picking the best health insurance policy for diabetic patients, it is essential to compare different options. Whether the individual is in search of the best health insurance for diabetics in India, type 2 diabetes health insurance, or type 1 diabetes health insurance, considering the benefits can help you make a good decision.

Zydus Lifesciences to develops world’s first shigellosis and typhoid combination vaccine

Aman Shukla — Tue, 04 Mar 2025 05:22:29 +0000

Zydus Lifesciences Limited, a global leader in life sciences and vaccine innovation, has announced its groundbreaking project to develop the world’s first combination vaccine against typhoid and shigellosis. This pioneering initiative underscores India’s growing capabilities in medical innovation, aiming to combat two deadly enteric diseases with a single shot.

The project, set to commence in March 2025, is backed by the Gates Foundation and will undergo early-stage development, animal immunogenicity studies, and regulatory preclinical toxicology assessments. Zydus will collaborate with a research partner to integrate its WHO-prequalified Typhoid Conjugate Vaccine (ZyVac™ TCV) with a Shigella vaccine, creating a novel and potentially life-saving solution.

Typhoid and shigellosis are major public health concerns, particularly in endemic regions. Typhoid fever, caused by Salmonella typhi, affects an estimated 11 to 21 million people annually, leading to thousands of deaths. Shigellosis, a severe diarrhoeal disease caused by Shigella bacteria, remains the second leading cause of diarrhoeal mortality, responsible for approximately 212,000 deaths worldwide. Recognizing the urgent need for intervention, the WHO recently listed Shigella as a priority pathogen for vaccine research and development.

Vaccination remains the most effective strategy to curb these infections. By combining protection against both diseases into a single vaccine, Zydus aims to enhance accessibility, affordability, and efficiency in immunization programs, particularly for children under five—the most vulnerable group. This innovative approach aligns with global immunization strategies and offers a potential breakthrough in tackling vaccine-preventable diseases in high-risk areas.

Zydus launches VaxiFlu-4, India’s latest flu vaccine for 2025

Aman Shukla — Wed, 26 Feb 2025 05:31:02 +0000

Zydus, one of the global pharmaceutical leaders, is set to launch VaxiFlu-4, India’s first quadrivalent influenza vaccine for the 2025 flu season. Designed as per WHO’s recommended composition, this inactivated vaccine offers protection against four flu strains, including A/Victoria/4897/2022 (H1N1), A/Croatia/10136RV/2023 (H3N2), B/Austria/1359417/2021 (B/Victoria), and B/Phuket/3073/2013 (B/Yamagata). By covering both influenza A and B strains, it provides broader protection and reduces the risk of vaccine mismatch.

Developed at Zydus’ Vaccine Technology Centre (VTC) in Ahmedabad, VaxiFlu-4 has been approved by the Central Drug Laboratory (CDL) and will be marketed under Zydus Vaxxicare, the company’s division dedicated to preventive healthcare. With its expertise in vaccine development, Zydus ensures that VaxiFlu-4 meets global safety and efficacy standards.

Influenza remains a major public health challenge, with seasonal outbreaks leading to 290,000-650,000 deaths globally every year, as per the World Health Organization (WHO). The virus spreads through airborne droplets from coughing and sneezing, as well as direct contact with infected surfaces. It can cause mild to severe illness, sometimes requiring hospitalization, especially among children, the elderly, and individuals with chronic conditions.

Annual flu vaccination is the most effective way to prevent influenza and its complications. With VaxiFlu-4, Zydus aims to strengthen India’s flu protection, ensuring better immunity and reduced disease burden in the upcoming flu season.

Sun Pharma and Philogen announce completion of patient enrollment for Phase III FIBROSARC trial

Matrika Shukla — Tue, 04 Feb 2025 10:52:15 +0000

Sun Pharmaceutical Industries Limited and Philogen S.p.A. have successfully completed patient enrollment for the Phase III FIBROSARC trial in Soft Tissue Sarcoma (STS), marking a significant milestone in their joint efforts to develop innovative oncology treatments.

The FIBROSARC trial, a pivotal Phase III study, aims to evaluate the efficacy of Fibromun (L19TNF) in combination with doxorubicin for the treatment of first-line locally advanced or metastatic STS. The trial, conducted across Germany, France, Italy, Spain, and Poland, has exceeded its enrollment target with 129 patients enrolled against the planned 118. Key results from this study are anticipated between March and June 2025.

Dario Neri, CEO of Philogen, expressed optimism about the progress of Fibromun’s clinical trials, stating, “We are highly encouraged by the advancements in Fibromun’s pivotal trials in both Soft Tissue Sarcoma and Glioblastoma. The completion of patient enrollment in FIBROSARC brings us one step closer to delivering an effective treatment option for STS patients. We look forward to key data readouts in the coming months.”

Sun Pharma’s Chairman and Managing Director, Dilip Shanghvi, highlighted the significance of this development in expanding the company’s oncology portfolio. “Fibromun has the potential to address high unmet medical needs in STS and other cancers. We eagerly anticipate the upcoming study results and remain committed to advancing innovative therapies,” he said.

The FIBROSARC trial is part of a broader research initiative that includes multiple ongoing clinical studies for Fibromun. The FLASH study, a Phase II trial for last-line STS treatment using Fibromun in combination with dacarbazine, has also exceeded its enrollment target with 94 patients recruited against the planned 86. Study results for FLASH are expected between April and July 2025.

In the United States, the Phase IIb FIBROSARC US study is evaluating Fibromun with doxorubicin in first-line metastatic Leiomyosarcoma patients, with 74 out of the planned 158 patients enrolled so far.

Beyond STS, Fibromun is also being investigated in Glioblastoma (GBM) through multiple clinical trials in Europe and the US. The Phase II GLIOSTAR trial in GBM has accelerated recruitment and is now expected to complete patient enrollment by Q2 2025, ahead of its original December 2025 target. Other GBM trials, including GLIOSTELLA and GLIOSUN, are progressing as planned, with data readouts expected in 2025 and 2026.

Fibromun is a proprietary biopharmaceutical product developed by Philogen, combining the L19 antibody with Tumor Necrosis Factor (TNF) to target tumor cells selectively. It is administered via intravenous infusion and is being explored for its potential to treat various cancers beyond STS and GBM, including lung, breast, colon, and prostate cancers.

Philogen and Sun Pharma have strengthened their collaboration through an exclusive global distribution, licensing, and supply agreement for Fibromun, further solidifying their joint commitment to advancing oncology treatments.

With promising study results on the horizon, the success of these clinical trials could pave the way for regulatory discussions, including a potential pre-Biologics License Application (pre-BLA) meeting with the U.S. FDA to explore accelerated approval pathways.

Natco Pharma secures USFDA approval for generic Everolimus tablets, eyes $112 million market

News Desk — Thu, 30 Jan 2025 04:01:44 +0000

Natco Pharma Limited has announced that it has received USFDA approval for its Abbreviated New Drug Application (ANDA) for Everolimus tablets for oral suspension (TFOS) in 2mg, 3mg, and 5mg strengths. The drug is a generic version of AFINITOR DISPERZ® by Novartis Pharmaceutical Corporation.

Natco’s marketing partner, Breckenridge Pharmaceutical, Inc., is set to launch the product immediately in the US market, tapping into an estimated $112 million sales opportunity for the 12 months ending September 2024, based on industry data.

Everolimus TFOS is a kinase inhibitor used to treat subependymal giant cell astrocytoma (SEGA) in adult and pediatric patients (aged one year and older) with tuberous sclerosis complex (TSC) when the tumor cannot be surgically removed.

Natco Pharma, headquartered in Hyderabad, India, specializes in generic and specialty pharmaceuticals, oncology drugs, and active pharmaceutical ingredients (APIs). The company has nine manufacturing sites and two R&D facilities in India, with regulatory approvals from the USFDA, Brazil ANVISA, Health Canada, WHO, and others. It serves over 50 global markets.

This approval strengthens Natco’s portfolio in the US market and reinforces its position as a leader in developing limited-competition molecules. The launch of Everolimus TFOS is expected to enhance Natco’s presence in the high-value US generics segment, leveraging its expertise in complex drug formulations.

Bajaj Healthcare secures DCGI approval to manufacture Pimavanserin in India

News Desk — Thu, 30 Jan 2025 03:48:55 +0000

Bajaj Healthcare Limited has received approval from the Drug Controller General of India (DCGI) to manufacture both the Active Pharmaceutical Ingredient (API) and Drug Formulation of Pimavanserin, a 34 mg capsule used to treat hallucinations and delusions associated with Parkinson’s disease psychosis.

Pimavanserin, marketed globally as NUPLAZID®, has gained significant traction in the US antipsychotic segment. Acadia Pharmaceuticals, which markets NUPLAZID®, recently projected that the drug, along with its other brand DAYBUE, is expected to generate over $1 billion in net sales in 2025.

Bajaj Healthcare has extended its offer to manufacture Pimavanserin for several leading Indian pharmaceutical companies, ensuring widespread availability in the domestic market.

Speaking on the development, Anil Jain, Managing Director of Bajaj Healthcare, emphasized the significance of this approval, stating, “This marks a major milestone for Bajaj Healthcare. The growing success of NUPLAZID® in the US highlights the global demand for this innovative therapy, and we are confident that its introduction in India will be a transformative advancement in the antipsychotic segment. This move further strengthens our presence in the central nervous system (CNS) segment and underscores our dedication to advancing healthcare solutions in India.”

Bajaj Healthcare, known for its strong manufacturing capabilities, aims to ensure that both the API and final product meet international quality standards. The company is leveraging its domestic presence and expertise to maximize the product’s success in India.

With this approval, Bajaj Healthcare aims to tap into the growing demand for advanced antipsychotic treatments in India. The move could also strengthen its position in the CNS segment and drive further growth in the Indian pharmaceutical sector.

This development comes at a time when India’s pharmaceutical industry is expanding its footprint in global markets, and Bajaj Healthcare’s approval for Pimavanserin production aligns with the company’s strategy to offer high-quality, innovative healthcare solutions.

Max India’s Antara Senior Care partners with Wellbeing Nutrition to enhance senior wellness

News Desk — Tue, 28 Jan 2025 06:56:49 +0000

Max India’s Antara Senior Care has partnered with Wellbeing Nutrition to co-develop nutraceutical products tailored for India’s growing senior population. This collaboration aims to bridge critical nutritional gaps, providing evidence-based wellness solutions to enhance senior health.

Antara, a wholly owned subsidiary of Max India, will leverage its expertise in senior care through its AGEasy platform, distributing these products via online and offline channels. According to studies, 27% of seniors in India are underweight, 76% have low vitamin D levels, and over 42% suffer from vitamin B12 deficiency, leading to cognitive decline and weakened immunity. This partnership aims to tackle these deficiencies through scientifically validated nutraceuticals.

Ishaan Khanna, CEO of Antara Assisted Care Services, highlighted that the collaboration with Wellbeing Nutrition aligns with Antara’s mission of providing accessible and innovative senior care solutions. He stated, “By developing tailored products, we aim to set a new benchmark in senior wellness in India, empowering seniors to lead healthier and more fulfilling lives.”

Avnish Chhabria, Founder of Wellbeing Nutrition, emphasized the need for scientifically backed nutritional solutions for seniors. He said, “This partnership enables us to bring clinically validated, research-backed wellness solutions to seniors, ensuring they receive high-quality nutrition to meet their unique health needs.”

Antara, launched in 2013 as part of the $5 billion Max Group, operates senior living residences and assisted care services in Gurgaon, Noida, and Bengaluru. Meanwhile, Wellbeing Nutrition, founded in 2019, is a leader in nutraceutical innovation, offering FDA-approved, gluten-free, and non-GMO products for holistic health.

This partnership represents a significant step in India’s senior care sector, ensuring that older adults have access to scientifically backed and clinically tested nutritional solutions for better longevity and well-being.

Bajaj Healthcare secures exclusive rights for Magtein® in India from Threotech LLC

News Desk — Thu, 16 Jan 2025 13:48:14 +0000

Bajaj Healthcare Limited has announced that it has received exclusive rights for the manufacturing, distribution, and sales of the finished formulation of Magnesium L Threonate (Magtein®) in India. This agreement has been established with Threotech LLC, the rights holder of the innovative product.

Under the agreement, Bajaj Healthcare will also have the authority to enter into marketing collaborations with leading pharmaceutical firms in India, thereby expanding its reach in the domestic market. The company already supplies the API Magnesium L Threonate (Magtein®) to Threotech LLC in the United States under an exclusive arrangement. The Magtein® brand has achieved a sales value of approximately USD 438 million in the U.S.

Anil Jain, Managing Director of Bajaj Healthcare, expressed enthusiasm about the development, stating, “Our collaboration with Threotech LLC has taken an exciting step forward. With our strong domestic presence and proven manufacturing and distribution expertise, we are well-positioned to unlock the product’s full potential in the Indian market. This development reaffirms our position as a trusted partner to our international clients.”

Magnesium L Threonate (Magtein®) is recognized for its nutraceutical benefits, with a focus on cognitive health, making it a highly innovative product in the global pharmaceutical market.

Bajaj Healthcare, established in 1993, is a leading manufacturer of APIs, intermediates, formulations, and nutraceuticals. With state-of-the-art facilities designed to cater to advanced and emerging markets, the company maintains a strong global presence in regions like the U.S., Europe, Australia, the Middle East, and South America.

This licensing agreement marks a significant milestone for Bajaj Healthcare as it expands its footprint in the Indian market while strengthening its collaboration with international partners.

Vein Conditions Decoded: A Comprehensive Guide by Dr. Sumit Kapadia

News Desk — Fri, 03 Jan 2025 13:16:45 +0000

For millions suffering from varicose veins, finding reliable treatment can feel like navigating through a maze of misinformation and unproven remedies. From ineffective oils to misguided home treatments, patients often waste precious time and resources before seeking professional help. This is where Dr. Sumit Kapadia comes to the rescue.

Dr. Kapadia, Director at Aadicura Superspeciality Hospital, Vadodara, whose evidence-based approach and extensive experience in treating over 25,000 patients have made him a trusted voice in vascular care.

“One of the most prevalent misconceptions I encounter is that all visible veins require immediate treatment,” Dr. Kapadia explains. “The reality is quite different. Approximately 70% of people with varicose veins don’t need any treatment at all. What’s crucial is getting a professional assessment to determine your specific case.”

When asked about popular home remedies, Dr. Kapadia’s expression turns serious. “I frequently see patients who’ve spent months or even years trying various gels, oils, and alternative treatments. Unfortunately, most of these solutions aren’t scientifically proven. It’s crucial to understand that while some home remedies might provide temporary relief, they don’t address the underlying cause.”

The conversation shifts to another dangerous myth – treating varicose veins as merely a cosmetic issue. “This is perhaps the most concerning misconception,” Dr. Kapadia emphasises. “While they may appear superficial, untreated varicose veins can lead to serious complications like deep vein thrombosis and chronic venous insufficiency. The statistics are alarming – about 40% of women globally suffer from this condition.”

Recognising the information gap, Dr. Kapadia has taken to YouTube to share evidence-based knowledge. “Through my channel, I aim to educate both the public and young medical professionals about modern treatment approaches,” he shares. “We now have access to non-surgical, minimally invasive solutions that allow for early recovery. The key is knowing when to seek professional help.”

As the interview concludes, Dr. Kapadia shares his vision: “My goal is to empower patients with accurate information. Whether through my hospital practice, online consultations, or educational content, I want to ensure that people have access to scientifically-backed treatment options when they need them.”

Through his multifaceted approach to patient education and treatment, Dr. Sumit Kapadia continues to bridge the information gap in vascular care, making reliable medical knowledge accessible to all.

Force Motors secures order for 2,429 ambulances from UP Government Health Department

News Desk — Thu, 02 Jan 2025 15:27:49 +0000

Force Motors Limited, a leader in commercial and specialty vehicle manufacturing, has been selected by the Uttar Pradesh Government Health Department to supply 2,429 ambulances. This significant order further cements Force Motors’ position as a trusted provider of emergency medical transport solutions in India.

The order includes the widely recognized Force Traveller Ambulance, renowned for its safety, reliability, and adaptability to diverse healthcare needs. The ambulances are available in customizable configurations, including Patient Transport, Basic Life Support (BLS), Advanced Life Support (ALS), and Mobile Medical Units (MMU). These vehicles are built to navigate India’s challenging terrains while ensuring patient comfort and safety.

With this procurement, the Uttar Pradesh Government aims to bolster its healthcare infrastructure and emergency response capabilities, benefiting millions across urban and rural areas. Commenting on the achievement, Mr. Prasan Firodia, Managing Director of Force Motors Limited, stated, “This milestone reinforces Force Motors’ commitment to delivering dependable, high-quality solutions tailored to India’s unique healthcare needs.”

Force Motors, a pioneer in the Indian automobile industry, continues to lead the ambulance segment, offering innovative solutions trusted by governments, hospitals, and NGOs nationwide.

Biocon Pharma receives NMPA approval for Tacrolimus capsules in China

Matrika Shukla — Thu, 02 Jan 2025 12:32:53 +0000

Biocon Pharma Limited, a wholly owned subsidiary of Biocon Limited, has received approval from the National Medical Products Administration (NMPA) in China for Tacrolimus capsules in 0.5mg, 1mg, and 5mg strengths. Tacrolimus, an immunosuppressant, is used to prevent organ rejection in transplant patients by suppressing the body’s immune response against the transplanted organ.

This approval adds another complex drug to Biocon’s growing portfolio and marks a significant step forward in the company’s global expansion strategy. Tacrolimus has a crucial role in post-transplant care, and its availability in China will help meet the increasing demand for immunosuppressants in the region. Biocon plans to quickly commercialize the drug, contributing to better access to essential treatments for transplant patients in China.

The NMPA approval reflects Biocon’s commitment to advancing healthcare by providing high-quality, affordable treatments in key international markets. This approval also enhances Biocon’s position as a leading player in complex generics and specialty pharmaceuticals globally.

Biocon is focused on expanding its footprint in the global market with an emphasis on complex drug products. The approval of Tacrolimus capsules is part of this strategy to bring advanced treatments to regions with significant medical needs.

IIT Bombay designs needle-free shock syringe for painless injections

Matrika Shukla — Sat, 28 Dec 2024 10:10:29 +0000

Needles are a source of anxiety for many, particularly for patients requiring frequent injections for chronic conditions like diabetes. Offering a potential breakthrough, researchers at IIT Bombay have developed a needle-free syringe, delivering drugs painlessly and safely using shockwave technology.

The innovative device, led by Prof. Viren Menezes from the Department of Aerospace Engineering, employs high-energy shock waves to create a microjet of liquid medication. This microjet penetrates the skin at nearly twice the speed of a commercial airplane during takeoff, ensuring minimal trauma and almost painless delivery.

How It Works

The device, roughly the size of a ballpoint pen, is equipped with a nozzle as fine as a human hair. This design ensures precise and comfortable drug delivery.

In laboratory tests on rats, the shock syringe demonstrated significant advantages:

Anesthetics: Matched needles effectively, acting within 3–5 minutes and lasting 20–30 minutes.
Viscous Drugs: Enhanced absorption by reaching deeper skin layers.
Insulin Delivery: Maintained stable blood sugar levels for longer durations.

Additionally, tissue analysis showed faster healing and reduced inflammation than traditional injections, suggesting the syringe’s suitability for repeated use.

Future Applications

This innovation holds great promise for vaccination campaigns, especially for children, and reduces the risk of infections from needle-related injuries. With over 1,000 successful uses in tests, the device offers a cost-effective solution, requiring only periodic nozzle replacements.

While further development and regulatory approvals are needed, the shock syringe could soon transform medical practices, making injections pain-free and safer for patients worldwide.

Dr. Reddy’s launches Toripalimab in India, a breakthrough immuno-oncology drug for nasopharyngeal carcinoma

News Desk — Thu, 28 Nov 2024 03:14:10 +0000

Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY) has launched Toripalimab in India, marking the country as the third globally to access this groundbreaking immuno-oncology drug after the United States and China. Toripalimab, marketed under the brand name Zytorvi®, is the first and only immunotherapy approved by leading regulatory bodies, including the USFDA, EMA, and India’s DCGI, for treating recurrent or metastatic nasopharyngeal carcinoma (RM-NPC).

Developed in collaboration with Shanghai Junshi Biosciences, the drug demonstrated a 48% reduction in the risk of disease progression or death when combined with standard chemotherapy. This launch aims to address a significant unmet need in India, which reports a high burden of NPC cases, especially in the northeastern states.

Dr. Reddy’s continues to prioritize oncology with an ecosystem of innovative cancer therapies and collaborations for novel molecules. CEO M.V. Ramana emphasized this milestone as part of the company’s commitment to improving cancer care access in emerging markets.

Disclaimer: This report is based on a press release and is for informational purposes only. It should not be considered medical or investment advice.

Dr. Reddy’s Laboratories launches Elobixibat (BixiBat®) to treat chronic constipation in India

Aman Shukla — Mon, 28 Oct 2024 11:18:39 +0000

Dr. Reddy’s Laboratories Ltd has announced the launch of BixiBat®, a first-in-class drug for treating chronic constipation in India. This innovative medication, known scientifically as Elobixibat, has received approval from the Central Drugs Standard Control Organisation (CDSCO) following the successful completion of Dr. Reddy’s Phase-3 clinical trials.

As the first company to introduce Elobixibat in India, Dr. Reddy’s aims to provide a new solution for those suffering from chronic constipation. It works by inhibiting the reabsorption of bile acids from the ileum, raising their concentration in the colonic lumen and causing increased bowel movements owing to stimulation of both colonic motility and fluid secretion, regardless of transit speed.

M.V. Ramana, Chief Executive Officer, Branded Markets (India and Emerging Markets), Dr. Reddy’s, stated, “The launch of this first-in-class drug is the latest in our continued efforts to bring novel molecules to patients in India. With over three decades of expertise and leadership in the gastrointestinal segment in India through trusted products such as Omez®, Razo™, Econorm®, and Redotil™, this latest offering will help us address unmet patient needs and further improve quality of life. The clinical studies for BixiBat® have demonstrated significantly better and promising outcomes, making it a breakthrough drug in the management of chronic constipation and enhancing the current standard of care for its treatment in India.”

Zydus Lifesciences gets USFDA approval to manufacture Fludrocortisone Acetate tablets

Aman Shukla — Thu, 17 Oct 2024 14:49:58 +0000

Zydus Lifesciences Limited has recently announced exchanges that the company received final approval from the United States Food and Drug Administration (USFDA) for the manufacture of Fludrocortisone Acetate Tablets USP, 0.1 mg.

Fludrocortisone acetate tablets are used as a partial replacement therapy for primary and secondary adrenocortical insufficiency in Addison’s disease, as well as to treat salt-losing adrenogenital syndrome. Fludrocortisone acetate tablets will be manufactured at the company’s facility in Moraiya, Ahmedabad.

The company presently has 400 approvals and has submitted over 465* ANDAs since the beginning of the filing process in FY 2003-04.

Lyka Labs receives CDSCO approval to manufacture and market Pregabalin Gel 8% w/w in India

Aman Shukla — Mon, 14 Oct 2024 12:28:00 +0000

Lyka Labs has obtained CDSCO approval to manufacture and market Pregabalin Gel 8% w/w in India. This novel topical treatment, aimed at alleviating Diabetic Neuropathic Pain (DNP), marks a crucial step forward in the management of diabetes-related neuropathy in India, where the prevalence of diabetes has risen dramatically.

Clinical trials showed that it is effective and well-tolerated, with fewer side effects than oral Pregabalin. This might be a great step for Lyka Labs.

Lyka is a pharmaceutical firm with a specialization in sterile and topical preparations. Lyka’s R&D Centre in Mumbai is actively developing a wide range of new formulations and drug delivery systems in its focus areas of Lyophilized Injectables and Topical Preparations.

Zydus and ICMR initiate Phase 2 trial of Desidustat for Sickle Cell Disease

News Desk — Mon, 14 Oct 2024 10:50:39 +0000

Zydus Lifesciences Limited and the Indian Council of Medical Research (ICMR) have commenced a Phase 2 proof-of-concept clinical trial for Desidustat in patients with Sickle Cell Disease (SCD). This trial, co-funded by the Indian National Clinical Trial and Education Network (INTENT), aims to evaluate the safety and efficacy of Desidustat in improving hemoglobin levels in SCD patients.

The double-blind, randomized, placebo-controlled trial will measure hemoglobin response as the primary endpoint, with secondary outcomes including the need for blood transfusions and incidence of vaso-occlusive crises. The study is being conducted across multiple centers in India and is registered under CTRI/2024/06/068363.

Dr. Rajiv Bahl, Director General of ICMR, emphasized the importance of this collaboration, stating that this effort underscores India’s focus on developing innovative healthcare solutions. Zydus Chairman Pankaj Patel highlighted the potential of the trial to contribute toward the goals of the National Sickle Cell Anemia Elimination Mission.

Sickle Cell Disease affects approximately 20 million people in India, with limited treatment options currently available. Desidustat, which is already approved for treating anemia in chronic kidney disease patients, offers hope for a novel therapy for managing this condition.

Panacea Biotec aims to launch dengue vaccine in next 2-3 years

News Desk — Fri, 11 Oct 2024 04:32:31 +0000

Panacea Biotec is gearing up to launch its dengue vaccine in the next 2-3 years, according to the company’s Chairman and Managing Director, Dr. Rajesh Jain. The vaccine, developed in collaboration with ICMR, is currently progressing through phase three clinical trials across 19 sites in India, covering over 10,000 adults.

In an exclusive interview with CNBC-TV18, Dr. Jain shared that the vaccine has been making significant strides, with clinical trials beginning on August 14, 2024. He expects the vaccine to be launched within two years, pending regulatory approval. Panacea Biotec’s efforts aim to introduce India’s first dengue vaccine, contributing significantly to the country’s healthcare sector.

Zydus Lifesciences receives USFDA approval for Paliperidone Extended-Release tablets

Aman Shukla — Thu, 10 Oct 2024 09:18:05 +0000

Zydus Lifesciences Limited has recently informed exchanges that the company received final United States Food and Drug Administration (USFDA) approval to manufacture Paliperidone Extended-Release Tablets, 1.5 mg, 3 mg, 6 mg, and 9 mg.

Paliperidone extended-release tablets are recommended for the acute and maintenance treatment of schizophrenia, the acute treatment of schizoaffective disorder as monotherapy and the acute treatment of schizoaffective disorder as an adjunct to mood stabilizers and/or antidepressants.

Paliperidone extended-release tablets will be manufactured in the Group’s Ahmedabad SEZ manufacturing facility.

Dr. Reddy’s Laboratories subsidiary announces promising Phase 1 results for autologous CAR-T cell therapy

Aman Shukla — Tue, 08 Oct 2024 10:48:46 +0000

Aurigene Oncology, a Dr. Reddy’s subsidiary, recently announced promising Phase 1 results for Ribrecabtagene autoleucel (DRL-1801), India’s first novel autologous CAR-T cell therapy for multiple myeloma.

The study, which included 8 heavily pre-treated patients, found 100% clinical response, with 62.5% achieving stringent complete response. The drug’s safety profile was positive with no high-grade events of CRS or neurotoxicity. The DCGI has approved Phase 2 trials based on the promising results.

Dr. Murali Ramachandra, CEO, Aurigene Oncology Limited, stated, “The results from the trial in heavily pre-treated relapsed refractory myeloma patients are very exciting for us in India. We are thrilled with the data, as the drug could be transformative for Indian patients with myeloma.”